# Deciphering the Roles & Regulation of Estradiol Signaling during Female Mini-Puberty: Insights from Mouse Models

Marie Devillers, Sakina Mhaouty-Kodja, Céline Guigon

<figure><img src="image_1.png" /></figure>

## ► To cite this version:

Marie Devillers, Sakina Mhaouty-Kodja, Céline Guigon. Deciphering the Roles & Regulation of Estradiol Signaling during Female Mini-Puberty: Insights from Mouse Models. International Journal of Molecular Sciences, 2022, 23 (22), pp.13695. 10.3390/ijms232213695. hal-04303738

HAL Id: hal-04303738

https://hal.science/hal-04303738

Submitted on 23 May 2024

HAL is a multi-disciplinary open access
archive for the deposit and dissemination of sci-
entific research documents, whether they are pub-
lished or not. The documents may come from
teaching and research institutions in France or
abroad, or from public or private research centers.

L'archive ouverte pluridisciplinaire HAL, est
destinée au dépôt et à la diffusion de documents
scientifiques de niveau recherche, publiés ou non,
émanant des établissements d'enseignement et de
recherche français ou étrangers, des laboratoires
publics ou privés.

<figure><img src="image_2.png" /></figure>
# Deciphering the Roles & Regulation of Estradiol Signaling during Female Mini-Puberty: Insights from Mouse Models

Marie Devillers, Sakina Mhaouty-Kodja, Céline Guigon

► To cite this version:

Marie Devillers, Sakina Mhaouty-Kodja, Céline Guigon. Deciphering the Roles & Regulation of Estradiol Signaling during Female Mini-Puberty: Insights from Mouse Models. International Journal of Molecular Sciences, 2022, 23 (22), pp.13695. 10.3390/ijms232213695. hal-04303738

HAL Id: hal-04303738

https://hal.science/hal-04303738v1

Submitted on 23 May 2024

HAL is a multi-disciplinary open access
archive for the deposit and dissemination of sci-
entific research documents, whether they are pub-
lished or not. The documents may come from
teaching and research institutions in France or
abroad, or from public or private research centers.

L'archive ouverte pluridisciplinaire HAL, est
destinée au dépôt et à la diffusion de documents
scientifiques de niveau recherche, publiés ou non,
émanant des établissements d'enseignement et de
recherche français ou étrangers, des laboratoires
publics ou privés.

<figure><img src="image_1.png" /></figure>

Distributed under a Creative Commons Attribution 4.0 International License
<figure><img src="image_3.png" /></figure>

Review

# Deciphering the Roles & Regulation of Estradiol Signaling during Female Mini-Puberty: Insights from Mouse Models

Marie M. Devillers <fnref n="1" />, Sakina Mhaouty-Kodja <fnref n="2" /> and Céline J. Guigon <fnref n="1" />,*

**Abstract:** Mini-puberty of infancy is a short developmental phase occurring in humans and other mammals after birth. In females, it corresponds to transient and robust activation of the hypothalamo-pituitary-ovarian (HPO) axis revealed by high levels of gonadotropin hormones, follicular growth, and increased estradiol production by the ovary. The roles of estradiol signaling during this intriguing developmental phase are not yet well known, but accumulating data support the idea that it aids in the implementation of reproductive function. This review aims to provide in-depth information on HPO activity during this particular developmental phase in several mammal species, including humans, and to propose emerging hypotheses on the putative effect of estradiol signaling on the development and function of organs involved in female reproduction.

**Keywords:** ovary; estradiol; estradiol receptor; hypothalamus; mini-puberty; GnRH

<figure><img src="image_4.png" /></figure>

check for
updates

**Citation:** Devillers, M.M.; Mhaouty-Kodja, S.; Guigon, C.J. Deciphering the Roles & Regulation of Estradiol Signaling during Female Mini-Puberty: Insights from Mouse Models. *Int. J. Mol. Sci.* **2022**, *23*, 13695. https://doi.org/10.3390/ijms232213695

Academic Editor: Emanuele Pelosi

Received: 25 September 2022

Accepted: 4 November 2022

Published: 8 November 2022

**Publisher's Note:** MDPI stays neutral with regard to jurisdictional claims in published maps and institutional affiliations.

<figure><img src="image_5.png" /></figure>

**Copyright:** © 2022 by the authors. Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (https://creativecommons.org/licenses/by/4.0/).

## 1. Introduction

Mini-puberty of infancy is an intriguing developmental period in mammals characterized by the postnatal activation of the hypothalamo-pituitary ovarian (HPO) axis (or gonadotrope axis) for a short duration. The term “mini-puberty” was first used in boys as the period of hormonal surge of gonadotropins and testosterone, which occurs in early infancy and contributes to the maturation of germ cells [1]. A wide array of studies has shown that both sexes display high levels of follicle-stimulating hormone (FSH) and luteinizing hormone (LH) and a gender-specific elevation of sex steroid hormones (testosterone in males and estradiol in females) postnatally. There is a sexual dimorphism in the surges of gonadotropins, with higher FSH levels in girls than in boys and higher LH levels in boys than in girls [2]. The postnatal elevation of testosterone levels in humans results in testicular descent, maturation of the testis, and penile growth [1,3]. It may also influence the masculinization of the brain, a process initiated during fetal life and mediated by testosterone produced by developing testes [3]. In male rodents, numerous studies, including the seminal work of Phoenix et al. on guinea pigs (1959) [4], showed that the perinatal period (end of gestation, first postnatal days) is critical for masculinization and defeminization of the nervous system. By contrast, mini-puberty has been far less studied in females, and its role remains elusive. Ovarian activity is particularly elevated after birth, with an intense synthesis and release of hormones, such as estrogens (estrone (E1) and estradiol (E2)). Their production depends upon the expression of steroidogenic enzymes, such as aromatase (CYP19A1), which ensures the conversion of androgens into estrogens. The balance between these biologically active metabolites, their precursors, and inactive sulfated sex steroids is controlled by the sulfotransferase (SULT)-sulfatase (STS) pathway (schematized in [5]). This notable ovarian activity occurs in time with the development of structures related to reproductive success. Estrogens may already act on several organs to influence their differentiation/maturation, particularly via the nuclear

<footnote n="1">¹ Sorbonne Paris Cité, Université de Paris Cité, CNRS, Inserm, Biologie Fonctionnelle et Adaptative UMR 8251, Physiologie de l'Axe Gonadotrope U1133, CEDEX 13, 75205 Paris, France</footnote>

<footnote n="2">² Neuroscience Paris Seine—Institut de Biologie Paris Seine, Sorbonne Université, CNRS UMR 8246, INSERM U1130, 75005 Paris, France</footnote>

<footnote>* Correspondence: celine.guigon@inserm.fr</footnote>
<figure><img src="image_2.png" /></figure>

Review

# Deciphering the Roles & Regulation of Estradiol Signaling during Female Mini-Puberty: Insights from Mouse Models

Marie M. Devillers <fnref n="1" />, Sakina Mhaouty-Kodja <fnref n="2" /> and Céline J. Guigon <fnref n="1" />,*

**Abstract:** Mini-puberty of infancy is a short developmental phase occurring in humans and other mammals after birth. In females, it corresponds to transient and robust activation of the hypothalamo-pituitary-ovarian (HPO) axis revealed by high levels of gonadotropin hormones, follicular growth, and increased estradiol production by the ovary. The roles of estradiol signaling during this intriguing developmental phase are not yet well known, but accumulating data support the idea that it aids in the implementation of reproductive function. This review aims to provide in-depth information on HPO activity during this particular developmental phase in several mammal species, including humans, and to propose emerging hypotheses on the putative effect of estradiol signaling on the development and function of organs involved in female reproduction.

**Keywords:** ovary; estradiol; estradiol receptor; hypothalamus; mini-puberty; GnRH

<figure><img src="image_3.png" /></figure>

check for
updates

**Citation:** Devillers, M.M.; Mhaouty-Kodja, S.; Guigon, C.J. Deciphering the Roles & Regulation of Estradiol Signaling during Female Mini-Puberty: Insights from Mouse Models. *Int. J. Mol. Sci.* **2022**, *23*, 13695. https://doi.org/10.3390/ijms232213695

Academic Editor: Emanuele Pelosi

Received: 25 September 2022

Accepted: 4 November 2022

Published: 8 November 2022

**Publisher's Note:** MDPI stays neutral with regard to jurisdictional claims in published maps and institutional affiliations.

<figure><img src="image_4.png" /></figure>

**Copyright:** © 2022 by the authors. Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (https://creativecommons.org/licenses/by/4.0/).

## 1. Introduction

Mini-puberty of infancy is an intriguing developmental period in mammals characterized by the postnatal activation of the hypothalamo-pituitary ovarian (HPO) axis (or gonadotrope axis) for a short duration. The term “mini-puberty” was first used in boys as the period of hormonal surge of gonadotropins and testosterone, which occurs in early infancy and contributes to the maturation of germ cells [1]. A wide array of studies has shown that both sexes display high levels of follicle-stimulating hormone (FSH) and luteinizing hormone (LH) and a gender-specific elevation of sex steroid hormones (testosterone in males and estradiol in females) postnatally. There is a sexual dimorphism in the surges of gonadotropins, with higher FSH levels in girls than in boys and higher LH levels in boys than in girls [2]. The postnatal elevation of testosterone levels in humans results in testicular descent, maturation of the testis, and penile growth [1,3]. It may also influence the masculinization of the brain, a process initiated during fetal life and mediated by testosterone produced by developing testes [3]. In male rodents, numerous studies, including the seminal work of Phoenix et al. on guinea pigs (1959) [4], showed that the perinatal period (end of gestation, first postnatal days) is critical for masculinization and defeminization of the nervous system. By contrast, mini-puberty has been far less studied in females, and its role remains elusive. Ovarian activity is particularly elevated after birth, with an intense synthesis and release of hormones, such as estrogens (estrone (E1) and estradiol (E2)). Their production depends upon the expression of steroidogenic enzymes, such as aromatase (CYP19A1), which ensures the conversion of androgens into estrogens. The balance between these biologically active metabolites, their precursors, and inactive sulfated sex steroids is controlled by the sulfotransferase (SULT)-sulfatase (STS) pathway (schematized in [5]). This notable ovarian activity occurs in time with the development of structures related to reproductive success. Estrogens may already act on several organs to influence their differentiation/maturation, particularly via the nuclear

<footnote n="1">¹ Sorbonne Paris Cité, Université de Paris Cité, CNRS, Inserm, Biologie Fonctionnelle et Adaptative UMR 8251, Physiologie de l'Axe Gonadotrope U1133, CEDEX 13, 75205 Paris, France</footnote>

<footnote n="2">² Neuroscience Paris Seine—Institut de Biologie Paris Seine, Sorbonne Université, CNRS UMR 8246, INSERM U1130, 75005 Paris, France</footnote>

<footnote>* Correspondence: celine.guigon@inserm.fr</footnote>
receptors ER (estrogen receptor), as discussed in this review. The conservation of this phase among female mammals suggests that this transient gonadotrope axis activation is important for reproductive function, but its role and regulation remain largely unexplored. In this review, we cover the literature on the activation of the HPO axis at mini-puberty, with a special focus on both the regulation of ovarian function and the potential role of this phase on reproductive success, mainly based on studies led in rodents. We will mainly discuss studies conducted in rodents since the literature on mini-puberty in humans has already been reviewed several times [6–8].

## 2. Defining HPO Axis Activation & Mini-Puberty Timing in Female Mammals

In female mammals, gonadotropins are already detected during fetal life. Their levels are schematized in mice at different periods of life (Figure 1; for humans [6,7]). This review will focus on their early regulation since the literature on this aspect of reproductive life, and reproductive senescence is abundant [9–11]. During fetal life, significant amounts of gonadotropins are detected (mouse: [12–14]; rabbit: [15]; human: [16,17]; rhesus monkey: [18]). LH and FSH start being detected at 16–17 days post-conception (dpc), i.e., 2–3 days before birth, in the female mouse [12,13] and at about 10–11 weeks of gestation in humans [17]. Their action on the fetal ovary may, however, greatly vary from one species to another. In humans and rhesus monkeys, gonadotropin signaling may become active by mid-term, as fetal ovaries are already a host of steroidogenesis with measurable androgens and estrogens. In addition, human fetal ovaries display growing follicles up to the antral stage at around five months of gestation [17,19–21]. The situation is different in rats and mice since, in these species, sex steroids become detectable after birth (around five days postnatal (dpn)) when gonadotropin receptivity and preantral follicles appear in the ovaries [22–24]. Gonadotropin levels then fall during perinatal life in humans [16–18,25,26], but not in mice [13].

The postnatal elevation of gonadotropin levels lasts for a few days in rodents and several months in larger mammals, including humans (Table 1). This is accompanied by a significant increase in ovarian activity, as shown by the elevation in estradiol levels. It is important to highlight that the duration of the mini-pubertal surges of gonadotropins and steroids may differ, with estradiol being much shorter (Table 1). The period of postnatal ovarian activity corresponds to mini-puberty [27–31]. Defining a precise time window of mini-puberty for a given species is difficult due to the considerable variability in gonadotropin/estradiol surges between individuals, the scarcity of longitudinal studies on the same subjects, and the poor reliability of commonly used hormone assays, in particular those for sex steroids. In girls, FSH levels increase at about one week of age and peak at 2–3 months, reaching values twice as high as those of women during the follicular or luteal phase [32]. They subsequently decline but remain higher than those of prepubertal girls until four years of age, remaining low up to puberty [33,34]. LH levels peak at around 1–3 months of age to decline after that, and unlike FSH, it does not reach levels above those of the menstrual cycle [32,33,35]. Estrone and estradiol are significantly produced by the human ovary during infancy [36] and can be detected in the serum [31,32]. Accurate determination of their levels by LC/MS-MS in children of different ages revealed that they are higher during the first three months of life (means: 35 pM and 10 pM, respectively) than in non-pubertal children (means: 10 pM and 3 pM, respectively), but they remain below those of the first days of the menstrual cycle (mean: 100 pM) [30].

In-depth analyses of the postnatal profiles of LH, FSH, and estradiol in rodents during the neonatal (0–7 dpn), infantile (8–17 dpn), and juvenile (17–30 dpn) periods (Figure 2A) and comparison with their profiles at puberty (occurring up to about 35 dpn in rats and 45 dpn in mice) and during reproductive life highlighted the tremendous activation of the gonadotrope axis during the infantile period in these species [27,29,30,37,38]. In rodents, the highest prepubertal FSH levels are reached at about 12–15 dpn, and we observed in mice that they are 3–5 times higher than at puberty or during reproductive life (Figure 2B) [27,29,30]. LH levels are elevated for about one week between 4 and 18 dpn,
receptors ER (estrogen receptor), as discussed in this review. The conservation of this phase among female mammals suggests that this transient gonadotrope axis activation is important for reproductive function, but its role and regulation remain largely unexplored. In this review, we cover the literature on the activation of the HPO axis at mini-puberty, with a special focus on both the regulation of ovarian function and the potential role of this phase on reproductive success, mainly based on studies led in rodents. We will mainly discuss studies conducted in rodents since the literature on mini-puberty in humans has already been reviewed several times [6–8].

## 2. Defining HPO Axis Activation & Mini-Puberty Timing in Female Mammals

In female mammals, gonadotropins are already detected during fetal life. Their levels are schematized in mice at different periods of life (Figure 1; for humans [6,7]). This review will focus on their early regulation since the literature on this aspect of reproductive life, and reproductive senescence is abundant [9–11]. During fetal life, significant amounts of gonadotropins are detected (mouse: [12–14]; rabbit: [15]; human: [16,17]; rhesus monkey: [18]). LH and FSH start being detected at 16–17 days post-conception (dpc), i.e., 2–3 days before birth, in the female mouse [12,13] and at about 10–11 weeks of gestation in humans [17]. Their action on the fetal ovary may, however, greatly vary from one species to another. In humans and rhesus monkeys, gonadotropin signaling may become active by mid-term, as fetal ovaries are already a host of steroidogenesis with measurable androgens and estrogens. In addition, human fetal ovaries display growing follicles up to the antral stage at around five months of gestation [17,19–21]. The situation is different in rats and mice since, in these species, sex steroids become detectable after birth (around five days postnatal (dpn)) when gonadotropin receptivity and preantral follicles appear in the ovaries [22–24]. Gonadotropin levels then fall during perinatal life in humans [16–18,25,26], but not in mice [13].

The postnatal elevation of gonadotropin levels lasts for a few days in rodents and several months in larger mammals, including humans (Table 1). This is accompanied by a significant increase in ovarian activity, as shown by the elevation in estradiol levels. It is important to highlight that the duration of the mini-pubertal surges of gonadotropins and steroids may differ, with estradiol being much shorter (Table 1). The period of postnatal ovarian activity corresponds to mini-puberty [27–31]. Defining a precise time window of mini-puberty for a given species is difficult due to the considerable variability in gonadotropin/estradiol surges between individuals, the scarcity of longitudinal studies on the same subjects, and the poor reliability of commonly used hormone assays, in particular those for sex steroids. In girls, FSH levels increase at about one week of age and peak at 2–3 months, reaching values twice as high as those of women during the follicular or luteal phase [32]. They subsequently decline but remain higher than those of prepubertal girls until four years of age, remaining low up to puberty [33,34]. LH levels peak at around 1–3 months of age to decline after that, and unlike FSH, it does not reach levels above those of the menstrual cycle [32,33,35]. Estrone and estradiol are significantly produced by the human ovary during infancy [36] and can be detected in the serum [31,32]. Accurate determination of their levels by LC/MS-MS in children of different ages revealed that they are higher during the first three months of life (means: 35 pM and 10 pM, respectively) than in non-pubertal children (means: 10 pM and 3 pM, respectively), but they remain below those of the first days of the menstrual cycle (mean: 100 pM) [30].

In-depth analyses of the postnatal profiles of LH, FSH, and estradiol in rodents during the neonatal (0–7 dpn), infantile (8–17 dpn), and juvenile (17–30 dpn) periods (Figure 2A) and comparison with their profiles at puberty (occurring up to about 35 dpn in rats and 45 dpn in mice) and during reproductive life highlighted the tremendous activation of the gonadotrope axis during the infantile period in these species [27,29,30,37,38]. In rodents, the highest prepubertal FSH levels are reached at about 12–15 dpn, and we observed in mice that they are 3–5 times higher than at puberty or during reproductive life (Figure 2B) [27,29,30]. LH levels are elevated for about one week between 4 and 18 dpn,
depending on rodent species and strains, and we found in mice that they reach values of the LH ovulatory surge at about 14 dpn (Figure 2B) [27,29,30,37,38]. Estradiol is detected in both the ovary and the serum as early as 5–7 dpn in mice and rats [29,30]. Circulating estradiol levels surge around 12–15 dpn, reaching preovulatory surge levels at 14 dpn in mice (Figure 2B) [29,30]. In contrast to the situation in humans where the “quiescence” of the HPO axis until the approach of puberty is relatively long (i.e., lasting for a minimum of 7 years), in rodents, there is a relatively short quiescence phase, lasting no more than 2–3 weeks.

<figure><img src="image_6.png" /><figcaption>**Figure 1.** Regulation of the gonadotrope axis at different periods of life in the mouse. FSH (green line) and LH (blue line) are detected in the last part of gestation, induced by GnRH stimulation. The high levels of maternal estrogens (dotted pink line) may not exert negative feedback at this time on FSH and LH synthesis and secretion due to high levels of α-fetoprotein (AFP) produced by the fetal liver. After birth, maternal estradiol wanes from pup serum, and this may lead to the loss of estradiol negative feedback and to the dramatic rise in gonadotropin levels observed at the time of mini-puberty. Additional ovarian factors may contribute to this rise (see the text). The gonadotropin surge contributes to increased estradiol production by the ovary at mini-puberty (continuous pink line). After that, the decrease in AFP after birth, and the maturation of inhibin negative feedback, may contribute to the observed fall in gonadotropin levels, remaining low up to puberty. During reproductive life, gonadotropin levels are regulated by both estradiol negative and positive feedback. Estradiol negative feedback in aged mice is attenuated, thereby increasing gonadotropin levels. Note that the levels of hormones shown during the different periods are given on an indicative basis since no studies encompass all these periods. See references in the text. The figure was prepared with the help of Mr. Le Ciclé, using BioRender, under Academic License terms.</figcaption></figure>
depending on rodent species and strains, and we found in mice that they reach values of the LH ovulatory surge at about 14 dpn (Figure 2B) [27,29,30,37,38]. Estradiol is detected in both the ovary and the serum as early as 5–7 dpn in mice and rats [29,30]. Circulating estradiol levels surge around 12–15 dpn, reaching preovulatory surge levels at 14 dpn in mice (Figure 2B) [29,30]. In contrast to the situation in humans where the “quiescence” of the HPO axis until the approach of puberty is relatively long (i.e., lasting for a minimum of 7 years), in rodents, there is a relatively short quiescence phase, lasting no more than 2–3 weeks.

<figure><img src="image_5.png" /><figcaption>**Figure 1.** Regulation of the gonadotrope axis at different periods of life in the mouse. FSH (green line) and LH (blue line) are detected in the last part of gestation, induced by GnRH stimulation. The high levels of maternal estrogens (dotted pink line) may not exert negative feedback at this time on FSH and LH synthesis and secretion due to high levels of α-fetoprotein (AFP) produced by the fetal liver. After birth, maternal estradiol wanes from pup serum, and this may lead to the loss of estradiol negative feedback and to the dramatic rise in gonadotropin levels observed at the time of mini-puberty. Additional ovarian factors may contribute to this rise (see the text). The gonadotropin surge contributes to increased estradiol production by the ovary at mini-puberty (continuous pink line). After that, the decrease in AFP after birth, and the maturation of inhibin negative feedback, may contribute to the observed fall in gonadotropin levels, remaining low up to puberty. During reproductive life, gonadotropin levels are regulated by both estradiol negative and positive feedback. Estradiol negative feedback in aged mice is attenuated, thereby increasing gonadotropin levels. Note that the levels of hormones shown during the different periods are given on an indicative basis since no studies encompass all these periods. See references in the text. The figure was prepared with the help of Mr. Le Ciclé, using BioRender, under Academic License terms.</figcaption></figure>
<table><caption>**Table 1.** Approximate ages of HPO activation and puberty in humans and different mammal species.
ND: not determined.</caption><thead><tr><th>Species</th><th>Ages at Gonadotropin Surge</th><th>Ages at Estradiol Surge</th><th>Ages at Puberty</th></tr></thead><tbody><tr><td>Mouse</td><td>FSH: 9-17 dpn; LH: 9-14 dpn [29]<br>FSH, LH: 4-18 dpn [37]<br>FSH: 11-16 dpn; LH: 11-14 dpn [38]</td><td>12-14 dpn [29]</td><td>28-45 dpn</td></tr><tr><td>Rat</td><td>FSH: 1-17 dpn; LH: 11-21 dpn [27]<br>FSH: 10-20 dpn; LH: 10-25 dpn [30]</td><td>9-19 dpn [27]<br>10-20 dpn [30]</td><td>28-35 dpn</td></tr><tr><td>Sheep</td><td>FSH: 2-7 weeks [39]<br>LH: ND</td><td>ND</td><td>25-35 weeks</td></tr><tr><td>Cow</td><td>FSH, LH: 2-14 weeks [40]</td><td>ND</td><td>6-20 months</td></tr><tr><td>Chimpanzee</td><td>FSH, LH: 1-4 months [33]<br>FSH, LH: 0.1-5 months [41]</td><td>ND</td><td>8-12 years</td></tr><tr><td>Rhesus Monkey</td><td>FSH: 0.5-4 months<br>LH: ND</td><td>ND</td><td>2.5-3 years</td></tr><tr><td>Human</td><td>FSH: 1-4 years, LH: 1-3 years [33]<br>FSH, LH: 1 year [32]<br>FSH, LH: 0.5-4 years [34]</td><td>6 months [32]<br>2-3 months [28,31]</td><td>8-14 years</td></tr></tbody></table>

<figure><img src="image_7.png" /></figure>

<figure><img src="image_8.png" /><figcaption>**Figure 2.** Significant changes in reproductive hormone levels during prepubertal life in the mouse. (A) The different stages of the prepubertal period in the mouse. The chronological axis displays the neonatal, infantile, and juvenile periods in this species. Mini-puberty takes place within the infantile period. (B) Gonadotropin and estradiol levels in prepubertal and adult female mice at different stages of the estrous cycle were determined by Luminex assay and GC/MS-MS, respectively, as published by our group in [29], including the additional age of 27 dpn analyzed at the same time as the other ages using the same methods. Hormonal levels of the infantile period are shown as blue bars.</figcaption></figure>

### 3. Possible Mechanisms Underlying Increasing Gonadotropin Levels during Fetal Life and Mini-Puberty

#### 3.1. Lack of Sensitivity to Estrogen Negative Feedback during Fetal Life

Gonadotropin-releasing hormone (GnRH) plays an important role in driving LH and FSH synthesis and release during the reproductive cycle. However, it may play an important role in regulating gonadotropins as soon as fetal life, as suggested by the onset of GnRH system activity (protein abundance, receptor binding, induction of gonadotropins) 2 to 3 days before birth in mice and at mid-gestation in humans, i.e., concomitantly with the observed increase in LH and FSH in the serum [12,42–45]. There is a marked sexual dimorphism in gonadotropin levels, which are generally much higher in females than
<table><caption>**Table 1.** Approximate ages of HPO activation and puberty in humans and different mammal species.
ND: not determined.</caption><thead><tr><th>Species</th><th>Ages at Gonadotropin Surge</th><th>Ages at Estradiol Surge</th><th>Ages at Puberty</th></tr></thead><tbody><tr><td>Mouse</td><td>FSH: 9–17 dpn; LH: 9–14 dpn [29]<br>FSH, LH: 4–18 dpn [37]<br>FSH: 11–16 dpn; LH: 11–14 dpn [38]</td><td>12–14 dpn [29]</td><td>28–45 dpn</td></tr><tr><td>Rat</td><td>FSH: 1–17 dpn; LH: 11–21 dpn [27]<br>FSH: 10–20 dpn; LH: 10–25 dpn [30]</td><td>9–19 dpn [27]<br>10–20 dpn [30]</td><td>28–35 dpn</td></tr><tr><td>Sheep</td><td>FSH: 2–7 weeks [39]<br>LH: ND</td><td>ND</td><td>25–35 weeks</td></tr><tr><td>Cow</td><td>FSH, LH: 2–14 weeks [40]</td><td>ND</td><td>6–20 months</td></tr><tr><td>Chimpanzee</td><td>FSH, LH: 1–4 months [33]<br>FSH, LH: 0.1–5 months [41]</td><td>ND</td><td>8–12 years</td></tr><tr><td>Rhesus Monkey</td><td>FSH: 0.5–4 months<br>LH: ND</td><td>ND</td><td>2.5–3 years</td></tr><tr><td>Human</td><td>FSH: 1–4 years, LH: 1–3 years [33]<br>FSH, LH: 1 year [32]<br>FSH, LH: 0.5–4 years [34]</td><td>6 months [32]<br>2–3 months [28,31]</td><td>8–14 years</td></tr></tbody></table>

<figure><img src="image_6.png" /></figure>

<figure><img src="image_7.png" /><figcaption>**Figure 2.** Significant changes in reproductive hormone levels during prepubertal life in the mouse. (A) The different stages of the prepubertal period in the mouse. The chronological axis displays the neonatal, infantile, and juvenile periods in this species. Mini-puberty takes place within the infantile period. (B) Gonadotropin and estradiol levels in prepubertal and adult female mice at different stages of the estrous cycle were determined by Luminex assay and GC/MS-MS, respectively, as published by our group in [29], including the additional age of 27 dpn analyzed at the same time as the other ages using the same methods. Hormonal levels of the infantile period are shown as blue bars.</figcaption></figure>

### 3. Possible Mechanisms Underlying Increasing Gonadotropin Levels during Fetal Life and Mini-Puberty

#### 3.1. Lack of Sensitivity to Estrogen Negative Feedback during Fetal Life

Gonadotropin-releasing hormone (GnRH) plays an important role in driving LH and FSH synthesis and release during the reproductive cycle. However, it may play an important role in regulating gonadotropins as soon as fetal life, as suggested by the onset of GnRH system activity (protein abundance, receptor binding, induction of gonadotropins) 2 to 3 days before birth in mice and at mid-gestation in humans, i.e., concomitantly with the observed increase in LH and FSH in the serum [12,42–45]. There is a marked sexual dimorphism in gonadotropin levels, which are generally much higher in females than
in males (mouse: [12-14]; rabbit: [15]; human: [16,17]; rhesus monkey: [18]). In males, testes produce testosterone during fetal life, while in females, ovaries do not produce sex steroids (in rodents). This marked increase in gonadotropin levels in the female fetus may result from the lack of negative feedback from the ovary to the hypothalamus and pituitary. However, in rodents, as in other mammal species, the fetus is exposed to high levels of maternal steroids. In addition, in some species, including humans, sex steroids are produced by fetal ovaries [21]. Therefore, another explanation could be that the action of estrogens at the hypothalamic level in the fetus is prevented by estrogen-binding proteins, such as alpha-fetoprotein (AFP) in mice, precluding crossing of the brain blood barrier [46] (Figure 1). Noteworthy, AFP has a very low affinity for estrogens in humans, and thus the identification of binding protein(s) during fetal life remains to be investigated in this species.

What could explain the decrease in fetal gonadotropin levels observed around the term in humans? The extremely high concentrations of maternal estrogens may allow the generation of free circulating estrogens to cross the fetal brain-blood-barrier and target the hypothalamus and the pituitary. Observations suggest that pre-term human infants, not exposed to high maternal estrogens at the end of pregnancy display higher amplitude and duration of FSH surge after birth [47].

## 3.2. Limited Negative Feedbacks Exerted by Estrogens and Inhibins at Mini-Puberty

The progressive increase in circulating LH and FSH levels observed at mini-puberty may result from the progressive disappearance of maternal steroids from the circulation of the offspring. Why do FSH levels generally display a more dramatic elevation in amplitude and duration than LH levels in females? During reproductive life, it is assumed that high-frequency GnRH pulses promote LH release, while low-frequency GnRH secretion induces high levels of FSH secretion. Studies conducted on rat postnatal hypothalamic explants suggest that the frequency of GnRH pulses is low at mini-puberty and progressively increases during the prepubertal period [48]. Hence, one of the current hypotheses is that low-frequency GnRH pulses favor FSH secretion over that of LH at mini-puberty [49]. On the other hand, the picture may be far more complex. Indeed, even if LH levels remain relatively lower than those of FSH at mini-puberty, its levels are still high. Additional mechanisms regulate gonadotrope function, such as local factors and ovarian hormones. The possibility that this differential regulation of FSH and LH is driven by ovarian factors is supported by our work in mini-pubertal rats, showing that the anti-müllerian hormone (AMH) stimulates FSH secretion but not that of LH [50]. This marked elevation of FSH could also arise from the low mini-pubertal production of inhibin A and B, which would not be able to exert a negative action on FSH synthesis, as suggested by observations in the rat reporting a negative correlation between FSH levels and those of inhibins during the prepubertal period [30].

The elevation of gonadotropin levels could also result from the weakness of estradiol negative feedback due to high levels of AFP, which restrict the availability of free estrogens, at least in rodents. Since AFP levels decline markedly at mini-puberty to become low at around 20 dpn, when gonadotropin levels decrease significantly [51,52], the estradiol negative feedback system may become fully active [53,54]. However, there is some evidence that this feedback is functional despite high levels of AFP since ovariectomy in rats during mini-puberty further increases FSH levels, an effect that is prevented by estradiol supplementation [54]. Negative feedback may also exist in primates since bilateral gonadectomy in rhesus monkeys during infancy results in increased LH and FSH levels [55]. In addition, girls with Turner syndrome usually suffering primary ovarian insufficiency with low to undetectable levels of ovarian hormones, exhibit higher levels of FSH than healthy girls during mini-puberty [2]. Furthermore, studies conducted in human infants reported that higher gonadotropin levels at birth in pre-term girls than in full-term girls are associated with lower serum levels of estradiol and inhibin B [56]. Overall, these data indicate that
in males (mouse: [12-14]; rabbit: [15]; human: [16,17]; rhesus monkey: [18]). In males, testes produce testosterone during fetal life, while in females, ovaries do not produce sex steroids (in rodents). This marked increase in gonadotropin levels in the female fetus may result from the lack of negative feedback from the ovary to the hypothalamus and pituitary. However, in rodents, as in other mammal species, the fetus is exposed to high levels of maternal steroids. In addition, in some species, including humans, sex steroids are produced by fetal ovaries [21]. Therefore, another explanation could be that the action of estrogens at the hypothalamic level in the fetus is prevented by estrogen-binding proteins, such as alpha-fetoprotein (AFP) in mice, precluding crossing of the brain blood barrier [46] (Figure 1). Noteworthy, AFP has a very low affinity for estrogens in humans, and thus the identification of binding protein(s) during fetal life remains to be investigated in this species.

What could explain the decrease in fetal gonadotropin levels observed around the term in humans? The extremely high concentrations of maternal estrogens may allow the generation of free circulating estrogens to cross the fetal brain-blood-barrier and target the hypothalamus and the pituitary. Observations suggest that pre-term human infants, not exposed to high maternal estrogens at the end of pregnancy display higher amplitude and duration of FSH surge after birth [47].

## 3.2. Limited Negative Feedbacks Exerted by Estrogens and Inhibins at Mini-Puberty

The progressive increase in circulating LH and FSH levels observed at mini-puberty may result from the progressive disappearance of maternal steroids from the circulation of the offspring. Why do FSH levels generally display a more dramatic elevation in amplitude and duration than LH levels in females? During reproductive life, it is assumed that high-frequency GnRH pulses promote LH release, while low-frequency GnRH secretion induces high levels of FSH secretion. Studies conducted on rat postnatal hypothalamic explants suggest that the frequency of GnRH pulses is low at mini-puberty and progressively increases during the prepubertal period [48]. Hence, one of the current hypotheses is that low-frequency GnRH pulses favor FSH secretion over that of LH at mini-puberty [49]. On the other hand, the picture may be far more complex. Indeed, even if LH levels remain relatively lower than those of FSH at mini-puberty, its levels are still high. Additional mechanisms regulate gonadotrope function, such as local factors and ovarian hormones. The possibility that this differential regulation of FSH and LH is driven by ovarian factors is supported by our work in mini-pubertal rats, showing that the anti-müllerian hormone (AMH) stimulates FSH secretion but not that of LH [50]. This marked elevation of FSH could also arise from the low mini-pubertal production of inhibin A and B, which would not be able to exert a negative action on FSH synthesis, as suggested by observations in the rat reporting a negative correlation between FSH levels and those of inhibins during the prepubertal period [30].

The elevation of gonadotropin levels could also result from the weakness of estradiol negative feedback due to high levels of AFP, which restrict the availability of free estrogens, at least in rodents. Since AFP levels decline markedly at mini-puberty to become low at around 20 dpn, when gonadotropin levels decrease significantly [51,52], the estradiol negative feedback system may become fully active [53,54]. However, there is some evidence that this feedback is functional despite high levels of AFP since ovariectomy in rats during mini-puberty further increases FSH levels, an effect that is prevented by estradiol supplementation [54]. Negative feedback may also exist in primates since bilateral gonadectomy in rhesus monkeys during infancy results in increased LH and FSH levels [55]. In addition, girls with Turner syndrome usually suffering primary ovarian insufficiency with low to undetectable levels of ovarian hormones, exhibit higher levels of FSH than healthy girls during mini-puberty [2]. Furthermore, studies conducted in human infants reported that higher gonadotropin levels at birth in pre-term girls than in full-term girls are associated with lower serum levels of estradiol and inhibin B [56]. Overall, these data indicate that
regulating gonadotropins during infancy involves multiple factors acting at different levels of the HPO axis.

**4. The Ovary: From Its Differentiation to Its Endocrine Activation at Mini-Puberty**

The mini-pubertal ovary is endowed with many growing follicles in addition to containing primordial follicles. Unlike the adult ovary, follicular growth does not proceed beyond the antral stage (Figure 3). These early-growing follicles display very specific features, which are discussed in more detail below.

<figure><img src="image_9.png" /><figcaption>**Figure 3.** Different categories of follicles are present in the prepubertal ovary in mammals. The prepubertal ovary is endowed with growing follicles up to the antral stage, and unlike the adult ovary during reproductive life, it does not display large healthy follicles of the size of preovulatory follicles despite high gonadotropin levels during mini-puberty.</figcaption></figure>

**4.1. Follicle Formation**

The formation of primordial follicles occurs after the fragmentation of ovigerous cords, which are structures containing oocytes arrested at the first prophase of meiosis and lined with pregranulosa cells. Depending on the species, this event occurs during fetal development (domestic mammals and humans) or around birth (rodents) [19,20,57,58]. However, in well-documented species such as rodents, fragmentation of ovigerous cords is reported to also give rise to primary-stage follicles, exhibiting enlarged oocyte size as well as cuboidal and proliferating granulosa cells [58]. Fragmentation of ovigerous cords starts from the center of the ovary at birth, yielding primary follicles, and progresses toward the periphery to give rise to primordial follicles around 4–5 dpn [59]. These primary follicles have never been in a dormant state, unlike primordial follicles. The emergence of these two populations of follicles may result from distinct waves of follicular cell differentiation, with the pregranulosa cells in primordial follicles migrating from the ovarian surface epithelium during perinatal life, whereas the granulosa cells in primary follicles would come from precursors from the coelomic epithelium of the bipotential gonad [60,61]. This concept of distinct waves of follicular cell recruitment to form two populations of follicles has also been proposed for sheep, in which a similar centrifugal pattern of follicular differentiation seems to occur [57]. It is unclear whether this also occurs in humans, where fragmentation of ovigerous cords spans from 19 to 35 weeks of gestation and primary follicles first appear around 21 weeks of gestation (for review [62]).

**4.2. Roles and Dynamics of the First Follicular Waves**

In rodents, primary follicles resulting from the fragmentation of ovigerous cords constitute the first follicular waves. They rapidly grow to the preantral and antral follicle stages at mini-puberty (Figure 3). The dogma that these first follicular waves are anovulatory and therefore degenerate through the process of atresia before puberty [58,63] has been challenged by two studies, including one from our group [64,65]. In a rat model
regulating gonadotropins during infancy involves multiple factors acting at different levels of the HPO axis.

**4. The Ovary: From Its Differentiation to Its Endocrine Activation at Mini-Puberty**

The mini-pubertal ovary is endowed with many growing follicles in addition to containing primordial follicles. Unlike the adult ovary, follicular growth does not proceed beyond the antral stage (Figure 3). These early-growing follicles display very specific features, which are discussed in more detail below.

<figure><img src="image_8.png" /><figcaption>**Figure 3.** Different categories of follicles are present in the prepubertal ovary in mammals. The prepubertal ovary is endowed with growing follicles up to the antral stage, and unlike the adult ovary during reproductive life, it does not display large healthy follicles of the size of preovulatory follicles despite high gonadotropin levels during mini-puberty.</figcaption></figure>

**4.1. Follicle Formation**

The formation of primordial follicles occurs after the fragmentation of ovigerous cords, which are structures containing oocytes arrested at the first prophase of meiosis and lined with pregranulosa cells. Depending on the species, this event occurs during fetal development (domestic mammals and humans) or around birth (rodents) [19,20,57,58]. However, in well-documented species such as rodents, fragmentation of ovigerous cords is reported to also give rise to primary-stage follicles, exhibiting enlarged oocyte size as well as cuboidal and proliferating granulosa cells [58]. Fragmentation of ovigerous cords starts from the center of the ovary at birth, yielding primary follicles, and progresses toward the periphery to give rise to primordial follicles around 4–5 dpn [59]. These primary follicles have never been in a dormant state, unlike primordial follicles. The emergence of these two populations of follicles may result from distinct waves of follicular cell differentiation, with the pregranulosa cells in primordial follicles migrating from the ovarian surface epithelium during perinatal life, whereas the granulosa cells in primary follicles would come from precursors from the coelomic epithelium of the bipotential gonad [60,61]. This concept of distinct waves of follicular cell recruitment to form two populations of follicles has also been proposed for sheep, in which a similar centrifugal pattern of follicular differentiation seems to occur [57]. It is unclear whether this also occurs in humans, where fragmentation of ovigerous cords spans from 19 to 35 weeks of gestation and primary follicles first appear around 21 weeks of gestation (for review [62]).

**4.2. Roles and Dynamics of the First Follicular Waves**

In rodents, primary follicles resulting from the fragmentation of ovigerous cords constitute the first follicular waves. They rapidly grow to the preantral and antral follicle stages at mini-puberty (Figure 3). The dogma that these first follicular waves are anovulatory and therefore degenerate through the process of atresia before puberty [58,63] has been challenged by two studies, including one from our group [64,65]. In a rat model
only containing the first follicular waves following depletion of primordial follicles dur-
ing the neonatal period (γ-irradiated rat model), it was shown that these growing folli-
cles are progressively eliminated by follicular atresia but that a subset of them achieves
their maturation to the ovulatory stage and contributes to the first sexual cycles of repro-
ductive life (2 months of age) [64,66]. This follicular population entirely disappears by
4–6 months of age due to depletion by atresia and ovulation [64]. Similar findings were
obtained in a more recent study conducted in a genetically modified mouse model, i.e., the
*Forkhead box L2 (Foxl2)-CreER<sup>T2</sup>; mT/mG* mice, allowing fluorescent tracing of the first follic-
ular waves and the primordial follicles over the prepubertal and adult periods [65]. This
model also revealed that primordial follicles begin to be recruited to the growing follicle
pool at approximately 13 dpn, i.e., at mini-puberty, thereby providing subsequent follicular
waves contributing to ovulations during reproductive life from about three months of age.
In humans, there is a long period between the appearance of the first growing follicles
during fetal life and the onset of puberty (8–14 years), and it is, thus, unlikely that the
growing follicles of the first follicular waves contribute to ovulation at puberty.

4.3. *Mechanisms Controlling Intra-Ovarian Estradiol Production during Mini-Puberty*

4.3.1. Regulation by Gonadotropins

In female mice and rats, ovaries express FSH receptors (FSHR) in granulosa cells early as birth and LH receptors (LHR) in thecal cells from 5 dpn [24,67,68]. Similar to cyclic females, LH stimulates androgen synthesis by thecal cells, and FSH promotes the aromatase-mediated conversion of thecal-derived androgens into estrogens in granulosa cells [69]. FSH also regulates follicular growth during this period, as shown by the early arrest of folliculogenesis at the preantral/early antral stage in FSH receptor ($Fshr^{-/^{-}}$) and Fsh beta subunit ($Fshb^{-/^{-}}$) knock-out mice during the infantile period (Balla et al., 2003) [70]. Gonadotropins are essential for early follicular development, as shown by the phenotype of *hypogonadal* (hpg) mice, which display lower counts of preantral follicles than wild-type females and no antral follicles at 8 dpn [71]. From the γ-irradiated rat model, we specified that follicles from the first waves at the preantral/small antral stage express *Cyp19a1* aromatase (the enzyme responsible for the conversion of androgens produced by thecal cells into estrogens by granulosa cells), and are responsible for the synthesis of estradiol throughout the prepubertal period [64]. Their granulosa cells also express *Lhcgr* (LHR) [29,64] (Figure 4). These findings indicate that these small follicles display premature endocrine maturation since *Cyp19a1* and *Lhcgr* are detected in granulosa cells at the large antral/preovulatory follicles in the adult ovary [72]. While the functionality of LHR signaling in granulosa cells remains to be demonstrated in mini-pubertal ovaries, it is likely that FSHR signaling stimulates estradiol production by inducing the expression of *Cyp19a1* [29,64,70]. In vitro analyses on isolated preantral follicles from 14 to 17 dpn (mini-pubertal) mouse ovaries confirmed the presence of *Fshr* and *Cyp19a1* transcripts [73]. Paradoxically, despite the mini-pubertal elevation of both FSH and LH levels at mini-puberty and the notable production of estradiol, follicles do not grow beyond the antral stage [29]. By manipulating gonadotropin levels in vivo in the mouse with a GnRH-R antagonist, we could demonstrate that high FSH levels up-regulate the expression of both *Lhcgr* and *Cyp19a1* and estradiol production from the first follicular waves. However, they are inefficient in inducing the expression of the cell cycle promoter Cyclin D2 (*Ccnd2*) and stimulating follicular growth [29]. Contrary to these findings, in vitro FSH treatment of preantral follicles from mini-pubertal mice induces both *Cyp19a1* and *Ccnd2* expression, and it has a follicular growth-promoting action [73]. We hypothesize that these contradictory data may result from differences in experimental settings (in vitro versus in vivo), on the type of used FSH (recombinant human FSH in Hardy et al., 2017 [73] versus pituitary-purified ovine FSH in François et al., 2017 [29]) and on FSH concentrations (10–100 ng/mL in vitro in Hardy et al., 2017 [73] to 150 ng/mL in vivo and 500 ng/mL ex vivo in François et al., 2017 [29]). The preferential action of elevated FSH levels on the steroidogenic pathway observed in vivo is further illustrated by the fact that treatment of mini-pubertal mice with exogenous gonadotropins following a super-
only containing the first follicular waves following depletion of primordial follicles during the neonatal period (γ-irradiated rat model), it was shown that these growing follicles are progressively eliminated by follicular atresia but that a subset of them achieves their maturation to the ovulatory stage and contributes to the first sexual cycles of reproductive life (2 months of age) [64,66]. This follicular population entirely disappears by 4–6 months of age due to depletion by atresia and ovulation [64]. Similar findings were obtained in a more recent study conducted in a genetically modified mouse model, i.e., the *Forkhead box L2 (Foxl2)-CreER*<sup>T2</sup>; *mT/mG* mice, allowing fluorescent tracing of the first follicular waves and the primordial follicles over the prepubertal and adult periods [65]. This model also revealed that primordial follicles begin to be recruited to the growing follicle pool at approximately 13 dpn, i.e., at mini-puberty, thereby providing subsequent follicular waves contributing to ovulations during reproductive life from about three months of age. In humans, there is a long period between the appearance of the first growing follicles during fetal life and the onset of puberty (8–14 years), and it is, thus, unlikely that the growing follicles of the first follicular waves contribute to ovulation at puberty.

## 4.3. Mechanisms Controlling Intra-Ovarian Estradiol Production during Mini-Puberty

### 4.3.1. Regulation by Gonadotropins

In female mice and rats, ovaries express FSH receptors (FSHR) in granulosa cells early as birth and LH receptors (LHR) in thecal cells from 5 dpn [24,67,68]. Similar to cyclic females, LH stimulates androgen synthesis by thecal cells, and FSH promotes the aromatase-mediated conversion of thecal-derived androgens into estrogens in granulosa cells [69]. FSH also regulates follicular growth during this period, as shown by the early arrest of folliculogenesis at the preantral/early antral stage in FSH receptor ($Fshr^{-/−}$) and Fsh beta subunit ($Fshb^{-/−}$) knock-out mice during the infantile period (Balla et al., 2003) [70]. Gonadotropins are essential for early follicular development, as shown by the phenotype of *hypogonadal* (hpg) mice, which display lower counts of preantral follicles than wild-type females and no antral follicles at 8 dpn [71]. From the γ-irradiated rat model, we specified that follicles from the first waves at the preantral/small antral stage express *Cyp19a1* aromatase (the enzyme responsible for the conversion of androgens produced by thecal cells into estrogens by granulosa cells), and are responsible for the synthesis of estradiol throughout the prepubertal period [64]. Their granulosa cells also express *Lhcgr* (LHR) [29,64] (Figure 4). These findings indicate that these small follicles display premature endocrine maturation since *Cyp19a1* and *Lhcgr* are detected in granulosa cells at the large antral/preovulatory follicles in the adult ovary [72]. While the functionality of LHR signaling in granulosa cells remains to be demonstrated in mini-pubertal ovaries, it is likely that FSHR signaling stimulates estradiol production by inducing the expression of *Cyp19a1* [29,64,70]. In vitro analyses on isolated preantral follicles from 14 to 17 dpn (mini-pubertal) mouse ovaries confirmed the presence of *Fshr* and *Cyp19a1* transcripts [73]. Paradoxically, despite the mini-pubertal elevation of both FSH and LH levels at mini-puberty and the notable production of estradiol, follicles do not grow beyond the antral stage [29]. By manipulating gonadotropin levels in vivo in the mouse with a GnRH-R antagonist, we could demonstrate that high FSH levels up-regulate the expression of both *Lhcgr* and *Cyp19a1* and estradiol production from the first follicular waves. However, they are inefficient in inducing the expression of the cell cycle promoter Cyclin D2 (*Ccnd2*) and stimulating follicular growth [29]. Contrary to these findings, in vitro FSH treatment of preantral follicles from mini-pubertal mice induces both *Cyp19a1* and *Ccnd2* expression, and it has a follicular growth-promoting action [73]. We hypothesize that these contradictory data may result from differences in experimental settings (in vitro versus in vivo), on the type of used FSH (recombinant human FSH in Hardy et al., 2017 [73] versus pituitary-purified ovine FSH in François et al., 2017 [29]) and on FSH concentrations (10–100 ng/mL in vitro in Hardy et al., 2017 [73] to 150 ng/mL in vivo and 500 ng/mL ex vivo in François et al., 2017 [29]). The preferential action of elevated FSH levels on the steroidogenic pathway observed in vivo is further illustrated by the fact that treatment of mini-pubertal mice with exogenous gonadotropins following a super-
ovulation procedure further increases estradiol levels without promoting preantral/early antral follicle growth [29]. Taken together, we hypothesize that gonadotropins stimulate estradiol synthesis in the first follicular waves only when they reach high concentrations, which are inefficient for follicular growth [29] (Figure 5). This mechanism may prevent premature ovulation.

<figure><img src="image_10.png" /></figure>

**Figure 4.** Particular characteristics of the first follicular waves in rodents. The first growing follicles are located in the central region of the ovary, delimited by dotted grey lines. Although most are destined to follicular atresia before puberty, a subset is ovulated at puberty and the very beginning of reproductive life [64,65]. The first follicular waves would be responsible for ovarian endocrine activity throughout prepubertal life [64]. During mini-puberty, immature follicles at the preantral/early antral stage show some functional characteristics of preovulatory follicles, such as *Cyp19a1* and *Lhcgr* expression in granulosa cells [29]. Scale bars: 100 µm.

<figure><img src="image_11.png" /></figure>

**Figure 5.** Proposed hypothesis on the dialogue between the ovary and the hypothalamo-pituitary system at mini-puberty. Estradiol produced by the first follicular waves may exert a negative feedback loop on the hypothalamus to restrain gonadotropin synthesis and secretion; however, the high levels of AFP may still limit its action. In contrast, we hypothesize that AMH produced by the subsequent follicular waves may up-regulate FSH synthesis by the pituitary and possibly LH and FSH levels by acting on GnRH neurons in the hypothalamus. See references in the text.
ovulation procedure further increases estradiol levels without promoting preantral/early antral follicle growth [29]. Taken together, we hypothesize that gonadotropins stimulate estradiol synthesis in the first follicular waves only when they reach high concentrations, which are inefficient for follicular growth [29] (Figure 5). This mechanism may prevent premature ovulation.

<figure><img src="image_9.png" /></figure>

**Figure 4.** Particular characteristics of the first follicular waves in rodents. The first growing follicles are located in the central region of the ovary, delimited by dotted grey lines. Although most are destined to follicular atresia before puberty, a subset is ovulated at puberty and the very beginning of reproductive life [64,65]. The first follicular waves would be responsible for ovarian endocrine activity throughout prepubertal life [64]. During mini-puberty, immature follicles at the preantral/early antral stage show some functional characteristics of preovulatory follicles, such as *Cyp19a1* and *Lhcgr* expression in granulosa cells [29]. Scale bars: 100 µm.

<figure><img src="image_10.png" /></figure>

**Figure 5.** Proposed hypothesis on the dialogue between the ovary and the hypothalamo-pituitary system at mini-puberty. Estradiol produced by the first follicular waves may exert a negative feedback loop on the hypothalamus to restrain gonadotropin synthesis and secretion; however, the high levels of AFP may still limit its action. In contrast, we hypothesize that AMH produced by the subsequent follicular waves may up-regulate FSH synthesis by the pituitary and possibly LH and FSH levels by acting on GnRH neurons in the hypothalamus. See references in the text.
### 4.3.2. Contribution of AMH Signaling

AMH is expressed by granulosa cells as soon as the primary follicle stage, and it disappears in antral follicles (except in cumulus cells) and atretic follicles [74]. AMH may inhibit the recruitment of primordial follicles into the growing pool and decrease the acquisition of FSH receptivity by antral follicles [75]. In mouse and rat ovaries, *Amh* expression in the first follicular waves progressively declines during mini-puberty, and its expression is essentially ensured by subsequent follicular waves located in the periphery [66,76]. We found that *Amh* down-regulation resulted from the mini-pubertal surge in FSH levels [76]. Similar to the adult ovary, AMH down-regulates *Cyp19a1* expression during mini-puberty [76]. Therefore, we hypothesize that FSH-induced down-regulation of AMH facilitates FSH-promoting action on estradiol biosynthesis by the first follicular waves [76], as described in the adult ovary [75,77,78]. Indeed, FSH-induced repression of *Amh* expression was observed in preantral follicles collected from mouse mini-pubertal ovaries and cultured in vitro [73]. The same may be true in mini-pubertal ewe lambs, where females with high FSH levels show low circulating AMH levels, while those with low FSH levels exhibit high AMH levels [39]. As highlighted above, AMH could also exert extra-gonadal actions, at least in rodents. Indeed, it could enhance GnRH neuron activity in the hypothalamus and LH secretion from the pituitary in adult females [79]. It could also directly act on the pituitary to increase FSH production and secretion in mini-pubertal females [50]. Although the origin of AMH acting on the hypothalamus and the pituitary remains elusive, it is tempting to suppose that ovarian AMH contributes to the activity of the gonadotrope axis during mini-puberty (Figure 5).

### 4.3.3. Effects of Exposure to Endocrine Disruptor Chemicals (EDCs) on Mini-Pubertal Estradiol Production

The potential impact of exposure to EDCs, specifically at the time of mini-puberty, remains largely unexplored. However, several studies have assessed developmental periods of exposure ranging from fetal to postnatal periods, including mini-puberty. The presence of metabolites of EDCs such as phthalates in maternal urine or cord blood, possibly lowering testosterone production, is associated with shorter anogenital distance and cryptorchidism in boys (for review, [80]). In girls, the relatively subtle changes in physical parameters during mini-puberty, and the need for more invasive investigations, may complicate studying EDC effects. However, assessment of pubertal markers in girls showed associations between phthalate or bisphenol A (BPA) metabolites and altered age of pubertal onset [81,82].

In recent studies carried out in rodents, we compared the impact of gestational/lactational versus mini-pubertal exposure to EDCs such as 2,3,7,8-tetrachlorodibenzo-p-dioxin (TCDD, the “Seveso dioxin”) reported to interfere with ER signaling or steroid synthesis upon binding to the aryl hydrocarbon receptor (AHR). TCDD affects the ovarian expression of *Cyp19a1* and estradiol production in juvenile and adult ovaries [83–85]. It induces the expression of detoxifying enzymes, for instance, *Cyp1a1*, to metabolize xenobiotic substances [86]. Studies in rodents exposed to TCDD in utero and during lactation up to weaning at around 20 dpn show that this compound causes delayed puberty, early alteration of estrous cycles, and impaired fertility [87]. Interestingly, in utero and lactational exposure to TCDD of female rats (gavage with 200 ng kg⁻¹ BW of the mother at 15.5 dpc) has no effect on the expression of steroidogenesis-related factors in the ovary during mini-puberty, although it induces AHR detoxifying machinery [88]. Similarly, intra-peritoneal TCDD injection of mini-pubertal mice at 13 dpn (5 mg kg⁻¹ BW) has no effect on steroidogenesis, but it activates the AHR detoxifying pathway in the mini-pubertal ovary [89]. These observations contrast with the fact that administration of the TCDD in mice at the approach of puberty stimulates estradiol synthesis in addition to activating the detoxifying pathway [89].

These findings suggest that although TCDD may activate AHR signaling during mini-puberty, it does not affect ovarian endocrine activity at this stage. Interestingly, even the
### 4.3.2. Contribution of AMH Signaling

AMH is expressed by granulosa cells as soon as the primary follicle stage, and it disappears in antral follicles (except in cumulus cells) and atretic follicles [74]. AMH may inhibit the recruitment of primordial follicles into the growing pool and decrease the acquisition of FSH receptivity by antral follicles [75]. In mouse and rat ovaries, *Amh* expression in the first follicular waves progressively declines during mini-puberty, and its expression is essentially ensured by subsequent follicular waves located in the periphery [66,76]. We found that *Amh* down-regulation resulted from the mini-pubertal surge in FSH levels [76]. Similar to the adult ovary, AMH down-regulates *Cyp19a1* expression during mini-puberty [76]. Therefore, we hypothesize that FSH-induced down-regulation of AMH facilitates FSH-promoting action on estradiol biosynthesis by the first follicular waves [76], as described in the adult ovary [75,77,78]. Indeed, FSH-induced repression of *Amh* expression was observed in preantral follicles collected from mouse mini-pubertal ovaries and cultured in vitro [73]. The same may be true in mini-pubertal ewe lambs, where females with high FSH levels show low circulating AMH levels, while those with low FSH levels exhibit high AMH levels [39]. As highlighted above, AMH could also exert extra-gonadal actions, at least in rodents. Indeed, it could enhance GnRH neuron activity in the hypothalamus and LH secretion from the pituitary in adult females [79]. It could also directly act on the pituitary to increase FSH production and secretion in mini-pubertal females [50]. Although the origin of AMH acting on the hypothalamus and the pituitary remains elusive, it is tempting to suppose that ovarian AMH contributes to the activity of the gonadotrope axis during mini-puberty (Figure 5).

### 4.3.3. Effects of Exposure to Endocrine Disruptor Chemicals (EDCs) on Mini-Pubertal Estradiol Production

The potential impact of exposure to EDCs, specifically at the time of mini-puberty, remains largely unexplored. However, several studies have assessed developmental periods of exposure ranging from fetal to postnatal periods, including mini-puberty. The presence of metabolites of EDCs such as phthalates in maternal urine or cord blood, possibly lowering testosterone production, is associated with shorter anogenital distance and cryptorchidism in boys (for review, [80]). In girls, the relatively subtle changes in physical parameters during mini-puberty, and the need for more invasive investigations, may complicate studying EDC effects. However, assessment of pubertal markers in girls showed associations between phthalate or bisphenol A (BPA) metabolites and altered age of pubertal onset [81,82].

In recent studies carried out in rodents, we compared the impact of gestational/lactational versus mini-pubertal exposure to EDCs such as 2,3,7,8-tetrachlorodibenzo-p-dioxin (TCDD, the “Seveso dioxin”) reported to interfere with ER signaling or steroid synthesis upon binding to the aryl hydrocarbon receptor (AHR). TCDD affects the ovarian expression of *Cyp19a1* and estradiol production in juvenile and adult ovaries [83–85]. It induces the expression of detoxifying enzymes, for instance, *Cyp1a1*, to metabolize xenobiotic substances [86]. Studies in rodents exposed to TCDD in utero and during lactation up to weaning at around 20 dpn show that this compound causes delayed puberty, early alteration of estrous cycles, and impaired fertility [87]. Interestingly, in utero and lactational exposure to TCDD of female rats (gavage with 200 ng kg⁻¹ BW of the mother at 15.5 dpc) has no effect on the expression of steroidogenesis-related factors in the ovary during mini-puberty, although it induces AHR detoxifying machinery [88]. Similarly, intraperitoneal TCDD injection of mini-pubertal mice at 13 dpn (5 mg kg⁻¹ BW) has no effect on steroidogenesis, but it activates the AHR detoxifying pathway in the mini-pubertal ovary [89]. These observations contrast with the fact that administration of the TCDD in mice at the approach of puberty stimulates estradiol synthesis in addition to activating the detoxifying pathway [89].

These findings suggest that although TCDD may activate AHR signaling during mini-puberty, it does not affect ovarian endocrine activity at this stage. Interestingly, even the
endogenous AHR pathway is unable to regulate estradiol synthesis during mini-puberty, unlike peripubertal mice, as suggested by studies on *Ahr* knock-out (*Ahr*⁻/⁻) mice [89]. These studies suggest that AHR-mediated EDC action depends on the stage of sexual maturity, as proposed [85]. However, this does not rule out that EDCs to which infants are exposed during mini-puberty, acting via AHR-independent mechanisms such as phthalates and BPA, may impact ovarian activity.

# 5. Putative Physiological Roles of Estradiol during Mini-Puberty

## 5.1. *Developmental Organization of the HPO Axis and Female Behavior*

During most of the cycle, low levels of estradiol suppress gonadotropin secretion through negative feedback exerted on the hypothalamus. In contrast, at the end of the follicular phase (proestrus in rodents), high estradiol levels trigger positive feedback that induces a large and continuous increase in GnRH release. This GnRH "surge," with an increase in gonadotrope cell responsiveness to GnRH, causes a surge in LH release from the pituitary. This ovulatory surge of LH occurs in all female mammals and is necessary for ovulation and sexual receptivity in rodents. The effects of estradiol on the regulation of GnRH secretion, either negative or positive, are integrated into the hypothalamus at the level of kisspeptin neurons, which express sex steroid receptors. These neurons represent major gatekeepers of pubertal onset and female reproduction (for review [90]). They send projections to cell bodies and terminal nerves of GnRH neurons, thereby activating both GnRH synthesis and liberation [91,92]. There are two kisspeptin neuronal populations in the murine hypothalamus, located in the rostral periventricular area of the third ventricle (RP3V) of the preoptic area (POA) and the arcuate nucleus (ARC). The RP3V population, which integrates the positive estradiol feedback to induce ovulation, is sexually dimorphic, with more kisspeptin neurons in females than in males [92].

The high levels of progesterone-induced by the preovulatory estradiol surge followed by the ovulatory LH surge activate the neural circuitry underlying female sexual behavior, including the receptive posture, called lordosis [93]. This circuitry includes the olfactory system and chemosensory areas, including the medial amygdala, the bed nucleus of stria terminalis, and the ventromedial hypothalamus, which processes the chemosignals into behavioral responses. All of these structures express high levels of ERα, with particularly high progesterone receptor expression in the ventromedial hypothalamus.

As reported above, the negative feedback system from the ovary to the hypothalamus may already be functional at birth. In contrast, the positive feedback loop may not be functional before puberty, possibly because POA kisspeptin neurons are not fully developed or not yet included in a functional network with GnRH neurons. Nevertheless, prepubertal ovarian estrogens exert a developmental control of neural structures involved in HPO axis regulation and female behaviors. Indeed, female mice with deletions in the *Cyp19a1* gene exhibit fewer hypothalamic kisspeptin neurons in the POA at 20 dpn and reduced lordosis behavior in adulthood [94–96]. Administration of estradiol to these knockout females during the infantile/juvenile period (15–25 dpn) partially restores these effects [96,97]. In addition, postnatal OVX at 15 dpn reduces the number of kisspeptin neurons in the POA, and adult estradiol supplementation restores it [98]. Studies of these and other experimental models have led to the idea that the period around 15 dpn in mice may be a critical window for exposure to estradiol on kisspeptin neurons, the age at puberty, and sexual behavior [98] (Figure 6). The possibility of an early estradiol action in females is further supported by the observation that ERα is expressed from birth (mRNAs and protein levels) in brain areas that will regulate the HPO axis and behaviors in adults [99–101]. In addition, genetic studies have shown that estrogens produced before puberty act through neural ERα and ERβ signaling pathways. Early embryonic *Esr2* deletion in the nervous system delays kisspeptin expression in prepubertal females and the onset of puberty [102]. Furthermore, early *Esr1* deletion in kisspeptin neurons or the nervous system accelerates pubertal onset, suppresses cyclicity and sexual behavior, and leads to an infertile phenotype [103,104].
endogenous AHR pathway is unable to regulate estradiol synthesis during mini-puberty, unlike peripubertal mice, as suggested by studies on *Ahr* knock-out (*Ahr*⁻/⁻) mice [89]. These studies suggest that AHR-mediated EDC action depends on the stage of sexual maturity, as proposed [85]. However, this does not rule out that EDCs to which infants are exposed during mini-puberty, acting via AHR-independent mechanisms such as phthalates and BPA, may impact ovarian activity.

# 5. Putative Physiological Roles of Estradiol during Mini-Puberty

## 5.1. *Developmental Organization of the HPO Axis and Female Behavior*

During most of the cycle, low levels of estradiol suppress gonadotropin secretion through negative feedback exerted on the hypothalamus. In contrast, at the end of the follicular phase (proestrus in rodents), high estradiol levels trigger positive feedback that induces a large and continuous increase in GnRH release. This GnRH "surge," with an increase in gonadotrope cell responsiveness to GnRH, causes a surge in LH release from the pituitary. This ovulatory surge of LH occurs in all female mammals and is necessary for ovulation and sexual receptivity in rodents. The effects of estradiol on the regulation of GnRH secretion, either negative or positive, are integrated into the hypothalamus at the level of kisspeptin neurons, which express sex steroid receptors. These neurons represent major gatekeepers of pubertal onset and female reproduction (for review [90]). They send projections to cell bodies and terminal nerves of GnRH neurons, thereby activating both GnRH synthesis and liberation [91,92]. There are two kisspeptin neuronal populations in the murine hypothalamus, located in the rostral periventricular area of the third ventricle (RP3V) of the preoptic area (POA) and the arcuate nucleus (ARC). The RP3V population, which integrates the positive estradiol feedback to induce ovulation, is sexually dimorphic, with more kisspeptin neurons in females than in males [92].

The high levels of progesterone-induced by the preovulatory estradiol surge followed by the ovulatory LH surge activate the neural circuitry underlying female sexual behavior, including the receptive posture, called lordosis [93]. This circuitry includes the olfactory system and chemosensory areas, including the medial amygdala, the bed nucleus of stria terminalis, and the ventromedial hypothalamus, which processes the chemosignals into behavioral responses. All of these structures express high levels of ERα, with particularly high progesterone receptor expression in the ventromedial hypothalamus.

As reported above, the negative feedback system from the ovary to the hypothalamus may already be functional at birth. In contrast, the positive feedback loop may not be functional before puberty, possibly because POA kisspeptin neurons are not fully developed or not yet included in a functional network with GnRH neurons. Nevertheless, prepubertal ovarian estrogens exert a developmental control of neural structures involved in HPO axis regulation and female behaviors. Indeed, female mice with deletions in the *Cyp19a1* gene exhibit fewer hypothalamic kisspeptin neurons in the POA at 20 dpn and reduced lordosis behavior in adulthood [94–96]. Administration of estradiol to these knockout females during the infantile/juvenile period (15–25 dpn) partially restores these effects [96,97]. In addition, postnatal OVX at 15 dpn reduces the number of kisspeptin neurons in the POA, and adult estradiol supplementation restores it [98]. Studies of these and other experimental models have led to the idea that the period around 15 dpn in mice may be a critical window for exposure to estradiol on kisspeptin neurons, the age at puberty, and sexual behavior [98] (Figure 6). The possibility of an early estradiol action in females is further supported by the observation that ERα is expressed from birth (mRNAs and protein levels) in brain areas that will regulate the HPO axis and behaviors in adults [99–101]. In addition, genetic studies have shown that estrogens produced before puberty act through neural ERα and ERβ signaling pathways. Early embryonic *Esr2* deletion in the nervous system delays kisspeptin expression in prepubertal females and the onset of puberty [102]. Furthermore, early *Esr1* deletion in kisspeptin neurons or the nervous system accelerates pubertal onset, suppresses cyclicity and sexual behavior, and leads to an infertile phenotype [103,104].
<figure><img src="image_12.png" /><figcaption>**Figure 6.** Possible roles of mini-pubertal estradiol on different organs related to reproduction. This hormone could play a pleiotropic role in the body by regulating the development and differentiation of several target tissues, including the hypothalamic system driving GnRH pulsatility, several brain areas contributing to sexual and maternal behaviors (amygdala, olfactory system, hypothalamus), the mammary gland and the uterus. See references in the text.</figcaption></figure>

## 5.2. Mammary Gland Development

The development of the mammary gland, a process referred to as mammogenesis, occurs during embryogenesis by the invagination of ectodermal structures to form epithelial buds surrounded by multi-layered mesenchymal cells. Epithelial cell proliferation and branching lead to the formation of a small ductal tree at birth. In mice, very little growth occurs between 11.5 and 16.5 dpc, but during the last few days of gestation, there is rapid proliferation of mammary epithelial cells, accompanied by penetration into the mammary fat pad precursor tissue. The involvement of ovarian hormones in mammary development was proposed from the observed sex dimorphism between males and females. While early mammogenesis occurs in the absence of gonadal sex steroids in the female mouse [105], it would be stimulated by high levels of maternal steroids in late gestation when there is rapid mammary gland growth. In males, the production of testosterone by the fetal testis leads to the apoptosis of the underlying mesenchymal cells that express the androgen receptor, and mammary glands remain rudimentary throughout life. In female mice and rats, extensive proliferation and branching of the mammary duct system occur between birth and puberty. Mammary gland growth is isometric (meaning that it grows at the same rate as the body) for 2 to 3 weeks, beginning around 7 dpn, and it becomes allometric (meaning that it grows faster than the other parts of the body) at puberty. This postnatal growth results in the development of a large number of end buds; in mice but not in rats, it could be estradiol-dependent, especially at puberty [106]. The binding of estradiol and expression of ER is observed in mammary epithelial cells during mini-puberty in the mouse [107,108]. However, mammary gland development proceeds to some extent in the absence of estradiol since the conditional loss of ERα in mammary epithelial cells arrests mammary gland development at the prepubertal stage [109]. However, in the mouse, most investigations have been carried out during the juvenile and pubertal periods, partly due to the prevailing view that estradiol production by the ovaries is negligible prior to puberty and that high levels of AFP prevent estradiol action [107]. Unlike mice, the role of postnatal estradiol in mammogenesis seems to be confirmed in cattle and goats, which show positive allometric mammary gland growth at the time of mini-puberty [110–113] (Figure 6). ERα expression is already detected in mammary epithelial cells at three months in calves [114]. Ovariectomy of mini-pubertal heifers and goats severely impairs the subsequent development of mammary glands, showing poorly organized epithelial structures, low cell proliferation and tissue remodeling [111,113]. In humans, ERα expression is ob-
<figure><img src="image_11.png" /><figcaption>**Figure 6.** Possible roles of mini-pubertal estradiol on different organs related to reproduction. This hormone could play a pleiotropic role in the body by regulating the development and differentiation of several target tissues, including the hypothalamic system driving GnRH pulsatility, several brain areas contributing to sexual and maternal behaviors (amygdala, olfactory system, hypothalamus), the mammary gland and the uterus. See references in the text.</figcaption></figure>

## 5.2. Mammary Gland Development

The development of the mammary gland, a process referred to as mammogenesis, occurs during embryogenesis by the invagination of ectodermal structures to form epithelial buds surrounded by multi-layered mesenchymal cells. Epithelial cell proliferation and branching lead to the formation of a small ductal tree at birth. In mice, very little growth occurs between 11.5 and 16.5 dpc, but during the last few days of gestation, there is rapid proliferation of mammary epithelial cells, accompanied by penetration into the mammary fat pad precursor tissue. The involvement of ovarian hormones in mammary development was proposed from the observed sex dimorphism between males and females. While early mammogenesis occurs in the absence of gonadal sex steroids in the female mouse [105], it would be stimulated by high levels of maternal steroids in late gestation when there is rapid mammary gland growth. In males, the production of testosterone by the fetal testis leads to the apoptosis of the underlying mesenchymal cells that express the androgen receptor, and mammary glands remain rudimentary throughout life. In female mice and rats, extensive proliferation and branching of the mammary duct system occur between birth and puberty. Mammary gland growth is isometric (meaning that it grows at the same rate as the body) for 2 to 3 weeks, beginning around 7 dpn, and it becomes allometric (meaning that it grows faster than the other parts of the body) at puberty. This postnatal growth results in the development of a large number of end buds; in mice but not in rats, it could be estradiol-dependent, especially at puberty [106]. The binding of estradiol and expression of ER is observed in mammary epithelial cells during mini-puberty in the mouse [107,108]. However, mammary gland development proceeds to some extent in the absence of estradiol since the conditional loss of ERα in mammary epithelial cells arrests mammary gland development at the prepubertal stage [109]. However, in the mouse, most investigations have been carried out during the juvenile and pubertal periods, partly due to the prevailing view that estradiol production by the ovaries is negligible prior to puberty and that high levels of AFP prevent estradiol action [107]. Unlike mice, the role of postnatal estradiol in mammogenesis seems to be confirmed in cattle and goats, which show positive allometric mammary gland growth at the time of mini-puberty [110–113] (Figure 6). ERα expression is already detected in mammary epithelial cells at three months in calves [114]. Ovariectomy of mini-pubertal heifers and goats severely impairs the subsequent development of mammary glands, showing poorly organized epithelial structures, low cell proliferation and tissue remodeling [111,113]. In humans, ERα expression is ob-
served in epithelial cell nuclei from the 30th week of gestation onwards, and it is markedly
up-regulated shortly after birth [115]. The observation supports the postnatal involvement
of ovarian hormones in mammary gland development that mammary gland diameter
decreases two months after birth in boys but not in girls and the fact that pre-term girls,
who have higher levels of estradiol than full-term girls, one month after birth, transiently
display enlarged mammary glands during mini-puberty [116]. In addition, a 6-week supple-
mentation starting at the birth of extremely premature infants (mean delivery age: 26 weeks)
with estradiol and progesterone leads to a dramatic increase in mammary gland diameter
4 to 5 weeks after birth [117].

5.3. *Uterus Development*

The uterus consists of two compartments, the myometrium and the endometrium, the inner mucosal lining of the uterus. The endometrium contains different cells, i.e., epithelial, stromal, immune, and endothelial cells. The epithelium is divided into two types: the luminal epithelium and the glandular epithelium forming the uterus glands and displaying an important role in supporting pregnancy by producing substances essential for the development and survival of the conceptus. The primitive uterus, also called Müllerian ducts, is not fully developed at birth in mammals, including cattle, humans, and rodents. Additional steps, such as differentiation and growth of the myometrium and epithelial glands, take place postnatally, including during mini-puberty.

The role of ovarian hormones and ER signaling on uterus development has been
widely studied and may be species-dependent. In rodents the uterus grows and develops
normally in the absence of ovaries following neonatal ovariectomy, but only for the first
three weeks after birth. The role of ovarian factors in subsequent uterus development
is shown by observing impaired uterine growth and maintenance of uterine glands in
neonatally ovariectomized females [118–120]. On the other hand, when these females
are supplemented with estradiol or progesterone during the neonatal period, their uterus
develops normally past three weeks of age, implying that early exposure to sex steroids
may have a long-term effect on this organ. ERα is expressed as early as 5 dpn in epithelial
and stromal cells in mice, but it shows a stronger expression in stromal cells [121]. Tissue
recombination studies indicate that epithelial ERα is neither necessary nor sufficient to
mediate the mitogenic action of estrogens on the epithelium. This would be primarily
mediated by stromal ERα via the production of stromal-derived growth factors such as
epidermal growth factor (EGF) and insulin growth factor (IGF) 1 and 2 [122,123]. Adult
mice lacking ERα (Esr1-null) have hypoplastic uteri containing all cell types in reduced
proportions, but fetal uterine organogenesis is normal [124,125]. In these mice, the initial
stages of uterine development and gland formation are normal from birth to 22 dpn, and
these processes are subsequently affected [120,126]. Importantly, when neonatal uteri
of Esr1-null mice are grafted into adult ovariectomized mice, estradiol stimulates graft
growth only in wild-type hosts, suggesting that this hormone stimulates the production
of a systemic growth factor of as yet unknown origin that would rely on extra-uterine
ERα-dependent mechanisms to promote uterine growth and gland formation [122]. Taken
together, these data indicate that estradiol would regulate uterine growth and development
by intra- and extra-uterine ERα-dependent signaling primarily from the juvenile period
in mice.

In sheep, ERα is already expressed during mini-puberty in several cell types of the
uterus, namely glandular epithelium, stromal cells, and myometrial cells [127].
Neonatal ovariectomy reduces uterus growth and the number of glands observed at
56 dpn (mini-puberty) [128]. In addition, in *Inverdale* ewes carrying a natural homozygous
mutation in the bone morphogenetic protein 15 (BMP15) gene, impaired ovarian function
is associated with a significant reduction in uterine growth and fewer uterine glands [129].
These data imply that ovarian hormones play a role in this process. However, estradiol
is unlikely to contribute to all the developmental and differentiation processes since the
administration of an anti-estrogen (ERα antagonist) from birth to 55 dpn alters endometrial
served in epithelial cell nuclei from the 30th week of gestation onwards, and it is markedly
up-regulated shortly after birth [115]. The observation supports the postnatal involvement
of ovarian hormones in mammary gland development that mammary gland diameter
decreases two months after birth in boys but not in girls and the fact that pre-term girls,
who have higher levels of estradiol than full-term girls, one month after birth, transiently
display enlarged mammary glands during mini-puberty [116]. In addition, a 6-week supple-
mentation starting at the birth of extremely premature infants (mean delivery age: 26 weeks)
with estradiol and progesterone leads to a dramatic increase in mammary gland diameter
4 to 5 weeks after birth [117].

5.3. *Uterus Development*

The uterus consists of two compartments, the myometrium and the endometrium, the inner mucosal lining of the uterus. The endometrium contains different cells, i.e., epithelial, stromal, immune, and endothelial cells. The epithelium is divided into two types: the luminal epithelium and the glandular epithelium forming the uterus glands and displaying an important role in supporting pregnancy by producing substances essential for the development and survival of the conceptus. The primitive uterus, also called Müllerian ducts, is not fully developed at birth in mammals, including cattle, humans, and rodents. Additional steps, such as differentiation and growth of the myometrium and epithelial glands, take place postnatally, including during mini-puberty.

The role of ovarian hormones and ER signaling on uterus development has been
widely studied and may be species-dependent. In rodents the uterus grows and develops
normally in the absence of ovaries following neonatal ovariectomy, but only for the first
three weeks after birth. The role of ovarian factors in subsequent uterus development
is shown by observing impaired uterine growth and maintenance of uterine glands in
neonatally ovariectomized females [118–120]. On the other hand, when these females
are supplemented with estradiol or progesterone during the neonatal period, their uterus
develops normally past three weeks of age, implying that early exposure to sex steroids
may have a long-term effect on this organ. ERα is expressed as early as 5 dpn in epithelial
and stromal cells in mice, but it shows a stronger expression in stromal cells [121]. Tissue
recombination studies indicate that epithelial ERα is neither necessary nor sufficient to
mediate the mitogenic action of estrogens on the epithelium. This would be primarily
mediated by stromal ERα via the production of stromal-derived growth factors such as
epidermal growth factor (EGF) and insulin growth factor (IGF) 1 and 2 [122,123]. Adult
mice lacking ERα (*Esr1*-null) have hypoplastic uteri containing all cell types in reduced
proportions, but fetal uterine organogenesis is normal [124,125]. In these mice, the initial
stages of uterine development and gland formation are normal from birth to 22 dpn, and
these processes are subsequently affected [120,126]. Importantly, when neonatal uteri
of *Esr1*-null mice are grafted into adult ovariectomized mice, estradiol stimulates graft
growth only in wild-type hosts, suggesting that this hormone stimulates the production
of a systemic growth factor of as yet unknown origin that would rely on extra-uterine
ERα-dependent mechanisms to promote uterine growth and gland formation [122]. Taken
together, these data indicate that estradiol would regulate uterine growth and development
by intra- and extra-uterine ERα-dependent signaling primarily from the juvenile period
in mice.

In sheep, ERα is already expressed during mini-puberty in several cell types of the
uterus, namely glandular epithelium, stromal cells, and myometrial cells [127].
Neonatal ovariectomy reduces uterus growth and the number of glands observed at
56 dpn (mini-puberty) [128]. In addition, in *Inverdale* ewes carrying a natural homozygous
mutation in the bone morphogenetic protein 15 (BMP15) gene, impaired ovarian function
is associated with a significant reduction in uterine growth and fewer uterine glands [129].
These data imply that ovarian hormones play a role in this process. However, estradiol
is unlikely to contribute to all the developmental and differentiation processes since the
administration of an anti-estrogen (ERα antagonist) from birth to 55 dpn alters endometrial
glands and ductal gland invaginations, but it does not affect uterus growth [127]. The deleterious effect of the exposure to supra-physiological doses of estradiol is supported by the observations that repeated injections of large amounts of estradiol-valerate from birth to 55 dpn inhibit uterine growth and endometrial gland differentiation, possibly by repressing ERα expression [127]. In humans, ERα mRNAs are detected in the uterus at 19 weeks of gestation, but the cell type expressing this receptor has not been reported [130]. Uterine length increases in pre-term girls compared with full-term girls at one month of age, positively correlated with urinary estradiol levels [116]. Additional evidence that the uterus is already the target of sex steroids after birth is provided by the observation that a 6-week replacement of estradiol and progesterone in pre-term infants dramatically enlarges the size of the uterus related to the control group (not replaced) group [117]. Taken together, these studies suggest that mini-pubertal ovarian activity, possibly through estradiol action, may regulate uterus development in some species during mini-puberty (Figure 6).

**6. Concluding Remarks, Perspectives and Future Directions**

Although recent investigations on mini-pubertal girls support the idea that this de-
velopmental phase has an important role in programming fertility by acting on different
levels of the reproductive system, some key experimental clues have been provided by
animal models, which will probably provide additional evidence in the future. As reported
in this review, estrogens appear necessary for the maturation of the Kiss-GnRH system in
the hypothalamus to modulate, *in fine*, the cyclic regulation of LH as well as sexual and
maternal behaviors. They could also influence the differentiation of both the mammary
gland and the uterus, probably in a species-dependent manner. Therefore, the postnatal
endocrine activity of the ovary could be of major importance for subsequent fertility. A
better understanding of the physiological role of this period and the regulation of the HPO
axis is essential to determine whether this could be a potential time window of vulnerability,
as suspected. Indeed, a visible advance in the age of puberty has been observed in recent
years in girls, and it is estimated that 6-20% of reproductive-aged women have fertility
defects due to polycystic ovarian syndrome (PCOS). Although the etiology of these defects
remains uncertain, it has been suggested that early disturbances of the sex steroid system
during fetal and postnatal life by daily exposure to EDCs with estrogenic, anti-estrogenic,
or anti-androgenic activities could be involved [131,132]. The possible deleterious impact of
EDCs on HPO activity and the differentiation of estradiol target organs during mini-puberty
has yet to be assessed to establish their long-term impacts on reproductive health.

**Author Contributions:** M.M.D. and C.J.G. wrote the initial draft, C.J.G. prepared the figures, S.M.-K. and C.J.G. edited the article. All authors have read and agreed to the published version of the manuscript.

**Funding:** This review is published with the financial support of ANR AAPG2020 (ReproFUN), CNRS, Inserm, Université Paris Cité, and Sorbonne Université.

**Conflicts of Interest:** The authors declare no conflict of interest.

**References**

1. Hadziselimovic, F.; Zivkovic, D.; Bica, D.T.G.; Emmons, L.R. The importance of mini-puberty for fertility in cryptorchidism. *J. Urol.* **2005**, *174*, 1536–1539, discussion 1538–1539. [CrossRef] [PubMed]

2. Johannsen, T.H.; Main, K.M.; Ljubicic, M.L.; Jensen, T.K.; Andersen, H.R.; Andersen, M.S.; Petersen, J.H.; Andersson, A.-M.; Juul, A. Sex Differences in Reproductive Hormones during Mini-Puberty in Infants with Normal and Disordered Sex Development. *J. Clin. Endocrinol. Metab.* **2018**, *103*, 3028–3037. [CrossRef] [PubMed]

3. Rey, R.A. Mini-puberty and true puberty: Differences in testicular function. *Ann. Endocrinol.* **2014**, *75*, 58–63. [CrossRef] [PubMed]

4. Phoenix, C.H.; Goy, R.W.; Gerall, A.A.; Young, W.C. Organizing action of prenatally administered testosterone propionate on the tissues mediating mating behavior in the female guinea pig. *Endocrinology* **1959**, *65*, 369–382. [CrossRef] [PubMed]

5. Tofovici, S.P.; Jackson, E.K. Estradiol Metabolism: Crossroads in Pulmonary Arterial Hypertension. *Int. J. Mol. Sci.* **2019**, *21*, 116. [CrossRef]

6. Lanciotti, L.; Cofini, M.; Leonardi, A.; Penta, L.; Esposito, S. Up-To-Date Review about Minipuberty and Overview on Hypothalamic-Pituitary-Gonadal Axis Activation in Fetal and Neonatal Life. *Front. Endocrinol.* **2018**, *9*, 410. [CrossRef]

7. Becker, M.; Hesse, V. Minipuberty: Why Does it Happen? *Horm. Res. Paediatr.* **2020**, *93*, 76–84. [CrossRef]
glands and ductal gland invaginations, but it does not affect uterus growth [127]. The deleterious effect of the exposure to supra-physiological doses of estradiol is supported by the observations that repeated injections of large amounts of estradiol-valerate from birth to 55 dpn inhibit uterine growth and endometrial gland differentiation, possibly by repressing ERα expression [127]. In humans, ERα mRNAs are detected in the uterus at 19 weeks of gestation, but the cell type expressing this receptor has not been reported [130]. Uterine length increases in pre-term girls compared with full-term girls at one month of age, positively correlated with urinary estradiol levels [116]. Additional evidence that the uterus is already the target of sex steroids after birth is provided by the observation that a 6-week replacement of estradiol and progesterone in pre-term infants dramatically enlarges the size of the uterus related to the control group (not replaced) group [117]. Taken together, these studies suggest that mini-pubertal ovarian activity, possibly through estradiol action, may regulate uterus development in some species during mini-puberty (Figure 6).

**6. Concluding Remarks, Perspectives and Future Directions**

Although recent investigations on mini-pubertal girls support the idea that this de-
velopmental phase has an important role in programming fertility by acting on different
levels of the reproductive system, some key experimental clues have been provided by
animal models, which will probably provide additional evidence in the future. As reported
in this review, estrogens appear necessary for the maturation of the Kiss-GnRH system in
the hypothalamus to modulate, *in fine*, the cyclic regulation of LH as well as sexual and
maternal behaviors. They could also influence the differentiation of both the mammary
gland and the uterus, probably in a species-dependent manner. Therefore, the postnatal
endocrine activity of the ovary could be of major importance for subsequent fertility. A
better understanding of the physiological role of this period and the regulation of the HPO
axis is essential to determine whether this could be a potential time window of vulnerability,
as suspected. Indeed, a visible advance in the age of puberty has been observed in recent
years in girls, and it is estimated that 6-20% of reproductive-aged women have fertility
defects due to polycystic ovarian syndrome (PCOS). Although the etiology of these defects
remains uncertain, it has been suggested that early disturbances of the sex steroid system
during fetal and postnatal life by daily exposure to EDCs with estrogenic, anti-estrogenic,
or anti-androgenic activities could be involved [131,132]. The possible deleterious impact of
EDCs on HPO activity and the differentiation of estradiol target organs during mini-puberty
has yet to be assessed to establish their long-term impacts on reproductive health.

**Author Contributions:** M.M.D. and C.J.G. wrote the initial draft, C.J.G. prepared the figures, S.M.-K. and C.J.G. edited the article. All authors have read and agreed to the published version of the manuscript.

**Funding:** This review is published with the financial support of ANR AAPG2020 (ReproFUN), CNRS, Inserm, Université Paris Cité, and Sorbonne Université.

**Conflicts of Interest:** The authors declare no conflict of interest.

**References**

1. Hadziselimovic, F.; Zivkovic, D.; Bica, D.T.G.; Emmons, L.R. The importance of mini-puberty for fertility in cryptorchidism. *J. Urol.* **2005**, *174*, 1536–1539, discussion 1538–1539. [CrossRef] [PubMed]

2. Johannsen, T.H.; Main, K.M.; Ljubicic, M.L.; Jensen, T.K.; Andersen, H.R.; Andersen, M.S.; Petersen, J.H.; Andersson, A.-M.; Juul, A. Sex Differences in Reproductive Hormones during Mini-Puberty in Infants with Normal and Disordered Sex Development. *J. Clin. Endocrinol. Metab.* **2018**, *103*, 3028–3037. [CrossRef] [PubMed]

3. Rey, R.A. Mini-puberty and true puberty: Differences in testicular function. *Ann. Endocrinol.* **2014**, *75*, 58–63. [CrossRef] [PubMed]

4. Phoenix, C.H.; Goy, R.W.; Gerall, A.A.; Young, W.C. Organizing action of prenatally administered testosterone propionate on the tissues mediating mating behavior in the female guinea pig. *Endocrinology* **1959**, *65*, 369–382. [CrossRef] [PubMed]

5. Tofovici, S.P.; Jackson, E.K. Estradiol Metabolism: Crossroads in Pulmonary Arterial Hypertension. *Int. J. Mol. Sci.* **2019**, *21*, 116. [CrossRef]

6. Lanciotti, L.; Cofini, M.; Leonardi, A.; Penta, L.; Esposito, S. Up-To-Date Review about Minipuberty and Overview on Hypothalamic-Pituitary-Gonadal Axis Activation in Fetal and Neonatal Life. *Front. Endocrinol.* **2018**, *9*, 410. [CrossRef]

7. Becker, M.; Hesse, V. Minipuberty: Why Does it Happen? *Horm. Res. Paediatr.* **2020**, *93*, 76–84. [CrossRef]
8. Bizzarri, C.; Cappa, M. Ontogeny of Hypothalamus-Pituitary Gonadal Axis and Minipuberty: An Ongoing Debate? *Front. Endocrinol.* **2020**, *11*, 187. [CrossRef]

9. Kermath, B.A.; Gore, A.C. Neuroendocrine control of the transition to reproductive senescence: Lessons learned from the female rodent model. *Neuroendocrinology* **2012**, *96*, 1–12. [CrossRef]

10. Oduwole, O.O.; Huhtaniemi, I.T.; Misrahi, M. The Roles of Luteinizing Hormone, Follicle-Stimulating Hormone and Testosterone in Spermatogenesis and Folliculogenesis Revisited. *Int. J. Mol. Sci.* **2021**, *22*, 12735. [CrossRef]

11. Parkening, T.A.; Collins, T.J.; Smith, E.R. Plasma and pituitary concentrations of luteinizing hormone, follicle-stimulating hormone and prolactin in aged, ovariectomized CD-1 and C57BL/6 mice. *Exp. Gerontol.* **1982**, *17*, 437–443. [CrossRef]

12. Pointis, G.; Latreille, M.T.; Cedard, L. Gonado-pituitary relationships in the fetal mouse at various times during sexual differentiation. *J. Endocrinol.* **1980**, *86*, 483–488. [CrossRef]

13. Stiff, M.E.; Bronson, F.H.; Stetson, M.H. Plasma gonadotropins in prenatal and prepubertal female mice: Disorganization of pubertal cycles in the absence of a male. *Endocrinology* **1974**, *94*, 492–496. [CrossRef]

14. Kreisman, M.J.; Song, C.I.; Yip, K.; Natale, B.V.; Natale, D.R.; Breen, K.M. Androgens Mediate Sex-Dependent Gonadotropin Expression during Late Prenatal Development in the Mouse. *Endocrinology* **2017**, *158*, 2884–2894. [CrossRef]

15. Veyssière, G.; Berger, M.; Jean-Faucher, C.; De Turckheim, M.; Jean, C. Pituitary and plasma levels of luteinizing hormone and follicle-stimulating hormone in male and female rabbit fetuses. *J. Endocrinol.* **1982**, *92*, 381–387. [CrossRef]

16. Takagi, S.; Yoshida, T.; Tsubata, K.; Ozaki, H.; Fujii, T.K.; Nomura, Y.; Sawada, M. Sex differences in fetal gonadotropins and androgens. *J. Steroid Biochem.* **1977**, *8*, 609–620. [CrossRef]

17. Reyes, F.I.; Boroditsky, R.S.; Winter, J.S.; Faiman, C. Studies on human sexual development. II. Fetal and maternal serum gonadotropin and sex steroid concentrations. *J. Clin. Endocrinol. Metab.* **1974**, *38*, 612–617. [CrossRef]

18. Ellinwood, W.E.; Resko, J.A. Sex differences in biologically active and immunoreactive gonadotropins in the fetal circulation of rhesus monkeys. *Endocrinology* **1980**, *107*, 902–907. [CrossRef]

19. Salfi, V.; Ventura, T.; Caraceni, D. Follicles development in the foetal human ovary. *Experientia* **1979**, *35*, 543–544. [CrossRef]

20. Ellinwood, W.E.; McClellan, M.C.; Brenner, R.M.; Resko, J.A. Estradiol synthesis by fetal monkey ovaries correlates with antral follicle formation. *Biol. Reprod.* **1983**, *28*, 505–516. [CrossRef]

21. Pezzi, V.; Mathis, J.M.; Rainey, W.E.; Carr, B.R. Profiling transcript levels for steroidogenic enzymes in fetal tissues. *J. Steroid Biochem. Mol. Biol.* **2003**, *87*, 181–189. [CrossRef]

22. Sokka, T.; Huhtaniemi, I. Ontogeny of gonadotrophin receptors and gonadotrophin-stimulated cyclic AMP production in the neonatal rat ovary. *J. Endocrinol.* **1990**, *127*, 297–303. [CrossRef]

23. Weniger, J.P.; Zeis, A.; Chouraqui, J. Estrogen production by fetal and infantile rat ovaries. *Reprod. Nutr. Dev.* **1993**, *33*, 129–136. [CrossRef]

24. O'Shaughnessy, P.J.; McLelland, D.; McBride, M.W. Regulation of luteinizing hormone-receptor and follicle-stimulating hormone-receptor messenger ribonucleic acid levels during development in the neonatal mouse ovary. *Biol. Reprod.* **1997**, *57*, 602–608. [CrossRef]

25. Kaplan, S.L.; Grumbach, M.M. The ontogenesis of human foetal hormones. II. Luteinizing hormone (LH) and follicle stimulating hormone (FSH). *Acta Endocrinol.* **1976**, *81*, 808–829. [CrossRef]

26. Beck-Peccoz, P.; Padmanabhan, V.; Baggiani, A.M.; Cortelazzi, D.; Buscaglia, M.; Medri, G.; Marconi, A.M.; Pardi, G.; Beitins, I.Z. Maturation of hypothalamic-pituitary-gonadal function in normal human fetuses: Circulating levels of gonadotropins, their common alpha-subunit and free testosterone, and discrepancy between immunological and biological activities of circulating follicle-stimulating hormone. *J. Clin. Endocrinol. Metab.* **1991**, *73*, 525–532. [CrossRef]

27. Döhler, K.D.; Wuttke, W. Changes with age in levels of serum gonadotropins, prolactin and gonadal steroids in prepubertal male and female rats. *Endocrinology* **1975**, *97*, 898–907. [CrossRef] [PubMed]

28. Chellakooty, M.; Schmidt, I.M.; Haavisto, A.M.; Boisen, K.A.; Damgaard, I.N.; Mau, C.; Petersen, J.H.; Juul, A.; Skakkebaek, N.E.; Main, K.M. Inhibin A, inhibin B, follicle-stimulating hormone, luteinizing hormone, estradiol, and sex hormone-binding globulin levels in 473 healthy infant girls. *J. Clin. Endocrinol. Metab.* **2003**, *88*, 3515–3520. [CrossRef] [PubMed]

29. François, C.M.; Petit, F.; Giton, F.; Gougeon, A.; Ravel, C.; Magre, S.; Cohen-Tannoudji, J.; Guigon, C.J. A novel action of follicle-stimulating hormone in the ovary promotes estradiol production without inducing excessive follicular growth before puberty. *Sci. Rep.* **2017**, *7*, 46222. [CrossRef] [PubMed]

30. Herath, C.B.; Yamashita, M.; Watanabe, G.; Jin, W.; Tangtrongsup, S.; Kojima, A.; Groome, N.P.; Suzuki, A.K.; Taya, K. Regulation of follicle-stimulating hormone secretion by estradiol and dimeric inhibins in the infantile female rat. *Biol. Reprod.* **2001**, *65*, 1623–1633. [CrossRef]

31. Frederiksen, H.; Johannsen, T.H.; Andersen, S.E.; Albrethsen, J.; Landersøe, S.K.; Petersen, J.H.; Andersen, A.N.; Vestergaard, E.T.; Schorring, M.E.; Linneberg, A.; et al. Sex-specific Estrogen Levels and Reference Intervals from Infancy to Late Adulthood Determined by LC-MS/MS. *J. Clin. Endocrinol. Metab.* **2020**, *105*, dgz196. [CrossRef]

32. Burger, H.G.; Yamada, Y.; Bangah, M.L.; McCloud, P.I.; Warne, G.L. Serum gonadotropin, sex steroid, and immunoreactive inhibin levels in the first two years of life. *J. Clin. Endocrinol. Metab.* **1991**, *72*, 682–686. [CrossRef]

33. Winter, J.S.; Faiman, C.; Hobson, W.C.; Prasad, A.V.; Reyes, F.I. Pituitary-gonadal relations in infancy. I. Patterns of serum gonadotropin concentrations from birth to four years of age in man and chimpanzee. *J. Clin. Endocrinol. Metab.* **1975**, *40*, 545–551. [CrossRef]
8. Bizzarri, C.; Cappa, M. Ontogeny of Hypothalamus-Pituitary Gonadal Axis and Minipuberty: An Ongoing Debate? *Front. Endocrinol.* **2020**, *11*, 187. [CrossRef]

9. Kermath, B.A.; Gore, A.C. Neuroendocrine control of the transition to reproductive senescence: Lessons learned from the female rodent model. *Neuroendocrinology* **2012**, *96*, 1–12. [CrossRef]

10. Oduwole, O.O.; Huhtaniemi, I.T.; Misrahi, M. The Roles of Luteinizing Hormone, Follicle-Stimulating Hormone and Testosterone in Spermatogenesis and Folliculogenesis Revisited. *Int. J. Mol. Sci.* **2021**, *22*, 12735. [CrossRef]

11. Parkening, T.A.; Collins, T.J.; Smith, E.R. Plasma and pituitary concentrations of luteinizing hormone, follicle-stimulating hormone and prolactin in aged, ovariectomized CD-1 and C57BL/6 mice. *Exp. Gerontol.* **1982**, *17*, 437–443. [CrossRef]

12. Pointis, G.; Latreille, M.T.; Cedard, L. Gonado-pituitary relationships in the fetal mouse at various times during sexual differentiation. *J. Endocrinol.* **1980**, *86*, 483–488. [CrossRef]

13. Stiff, M.E.; Bronson, F.H.; Stetson, M.H. Plasma gonadotropins in prenatal and prepubertal female mice: Disorganization of pubertal cycles in the absence of a male. *Endocrinology* **1974**, *94*, 492–496. [CrossRef]

14. Kreisman, M.J.; Song, C.I.; Yip, K.; Natale, B.V.; Natale, D.R.; Breen, K.M. Androgens Mediate Sex-Dependent Gonadotropin Expression during Late Prenatal Development in the Mouse. *Endocrinology* **2017**, *158*, 2884–2894. [CrossRef]

15. Veyssière, G.; Berger, M.; Jean-Faucher, C.; De Turckheim, M.; Jean, C. Pituitary and plasma levels of luteinizing hormone and follicle-stimulating hormone in male and female rabbit fetuses. *J. Endocrinol.* **1982**, *92*, 381–387. [CrossRef]

16. Takagi, S.; Yoshida, T.; Tsubata, K.; Ozaki, H.; Fujii, T.K.; Nomura, Y.; Sawada, M. Sex differences in fetal gonadotropins and androgens. *J. Steroid Biochem.* **1977**, *8*, 609–620. [CrossRef]

17. Reyes, F.I.; Boroditsky, R.S.; Winter, J.S.; Faiman, C. Studies on human sexual development. II. Fetal and maternal serum gonadotropin and sex steroid concentrations. *J. Clin. Endocrinol. Metab.* **1974**, *38*, 612–617. [CrossRef]

18. Ellinwood, W.E.; Resko, J.A. Sex differences in biologically active and immunoreactive gonadotropins in the fetal circulation of rhesus monkeys. *Endocrinology* **1980**, *107*, 902–907. [CrossRef]

19. Salfi, V.; Ventura, T.; Caraceni, D. Follicles development in the foetal human ovary. *Experientia* **1979**, *35*, 543–544. [CrossRef]

20. Ellinwood, W.E.; McClellan, M.C.; Brenner, R.M.; Resko, J.A. Estradiol synthesis by fetal monkey ovaries correlates with antral follicle formation. *Biol. Reprod.* **1983**, *28*, 505–516. [CrossRef]

21. Pezzi, V.; Mathis, J.M.; Rainey, W.E.; Carr, B.R. Profiling transcript levels for steroidogenic enzymes in fetal tissues. *J. Steroid Biochem. Mol. Biol.* **2003**, *87*, 181–189. [CrossRef]

22. Sokka, T.; Huhtaniemi, I. Ontogeny of gonadotrophin receptors and gonadotrophin-stimulated cyclic AMP production in the neonatal rat ovary. *J. Endocrinol.* **1990**, *127*, 297–303. [CrossRef]

23. Weniger, J.P.; Zeis, A.; Chouraqui, J. Estrogen production by fetal and infantile rat ovaries. *Reprod. Nutr. Dev.* **1993**, *33*, 129–136. [CrossRef]

24. O'Shaughnessy, P.J.; McLelland, D.; McBride, M.W. Regulation of luteinizing hormone-receptor and follicle-stimulating hormone-receptor messenger ribonucleic acid levels during development in the neonatal mouse ovary. *Biol. Reprod.* **1997**, *57*, 602–608. [CrossRef]

25. Kaplan, S.L.; Grumbach, M.M. The ontogenesis of human foetal hormones. II. Luteinizing hormone (LH) and follicle stimulating hormone (FSH). *Acta Endocrinol.* **1976**, *81*, 808–829. [CrossRef]

26. Beck-Peccoz, P.; Padmanabhan, V.; Baggiani, A.M.; Cortelazzi, D.; Buscaglia, M.; Medri, G.; Marconi, A.M.; Pardi, G.; Beitins, I.Z. Maturation of hypothalamic-pituitary-gonadal function in normal human fetuses: Circulating levels of gonadotropins, their common alpha-subunit and free testosterone, and discrepancy between immunological and biological activities of circulating follicle-stimulating hormone. *J. Clin. Endocrinol. Metab.* **1991**, *73*, 525–532. [CrossRef]

27. Döhler, K.D.; Wuttke, W. Changes with age in levels of serum gonadotropins, prolactin and gonadal steroids in prepubertal male and female rats. *Endocrinology* **1975**, *97*, 898–907. [CrossRef] [PubMed]

28. Chellakooty, M.; Schmidt, I.M.; Haavisto, A.M.; Boisen, K.A.; Damgaard, I.N.; Mau, C.; Petersen, J.H.; Juul, A.; Skakkebaek, N.E.; Main, K.M. Inhibin A, inhibin B, follicle-stimulating hormone, luteinizing hormone, estradiol, and sex hormone-binding globulin levels in 473 healthy infant girls. *J. Clin. Endocrinol. Metab.* **2003**, *88*, 3515–3520. [CrossRef] [PubMed]

29. François, C.M.; Petit, F.; Giton, F.; Gougeon, A.; Ravel, C.; Magre, S.; Cohen-Tannoudji, J.; Guigon, C.J. A novel action of follicle-stimulating hormone in the ovary promotes estradiol production without inducing excessive follicular growth before puberty. *Sci. Rep.* **2017**, *7*, 46222. [CrossRef] [PubMed]

30. Herath, C.B.; Yamashita, M.; Watanabe, G.; Jin, W.; Tangtrongsup, S.; Kojima, A.; Groome, N.P.; Suzuki, A.K.; Taya, K. Regulation of follicle-stimulating hormone secretion by estradiol and dimeric inhibins in the infantile female rat. *Biol. Reprod.* **2001**, *65*, 1623–1633. [CrossRef]

31. Frederiksen, H.; Johannsen, T.H.; Andersen, S.E.; Albrethsen, J.; Landersøe, S.K.; Petersen, J.H.; Andersen, A.N.; Vestergaard, E.T.; Schorring, M.E.; Linneberg, A.; et al. Sex-specific Estrogen Levels and Reference Intervals from Infancy to Late Adulthood Determined by LC-MS/MS. *J. Clin. Endocrinol. Metab.* **2020**, *105*, dgz196. [CrossRef]

32. Burger, H.G.; Yamada, Y.; Bangah, M.L.; McCloud, P.I.; Warne, G.L. Serum gonadotropin, sex steroid, and immunoreactive inhibin levels in the first two years of life. *J. Clin. Endocrinol. Metab.* **1991**, *72*, 682–686. [CrossRef]

33. Winter, J.S.; Faiman, C.; Hobson, W.C.; Prasad, A.V.; Reyes, F.I. Pituitary-gonadal relations in infancy. I. Patterns of serum gonadotropin concentrations from birth to four years of age in man and chimpanzee. *J. Clin. Endocrinol. Metab.* **1975**, *40*, 545–551. [CrossRef]
34. Penny, R.; Olambiwonnu, N.O.; Frasier, S.D. Serum gonadotropin concentrations during the first four years of life. *J. Clin. Endocrinol. Metab.* **1974**, *38*, 320–321. [CrossRef]

35. Schmidt, H.; Schwarz, H.P. Serum concentrations of LH and FSH in the healthy newborn. *Eur. J. Endocrinol.* **2000**, *143*, 213–215. [CrossRef]

36. Bidlingmaier, F.; Strom, T.M.; Dörr, H.G.; Eisenmenger, W.; Knorr, D. Estrone and estradiol concentrations in human ovaries, testes, and adrenals during the first two years of life. *J. Clin. Endocrinol. Metab.* **1987**, *65*, 862–867. [CrossRef]

37. Dullaart, J.; Kent, J.; Ryle, M. Serum gonadotrophin concentrations in infantile female mice. *J. Reprod. Fertil.* **1975**, *43*, 189–192. [CrossRef]

38. Michael, S.D.; Kaplan, S.B.; Macmillan, B.T. Peripheral plasma concentrations of LH, FSH, prolactin and GH from birth to puberty in male and female mice. *J. Reprod. Fertil.* **1980**, *59*, 217–222. [CrossRef]

39. Torres-Rovira, L.; Succu, S.; Pasciu, V.; Manca, M.E.; Gonzalez-Bulnes, A.; Leoni, G.G.; Pennino, M.G.; Spezzigu, A.; Gallus, M.; Dattena, M.; et al. Postnatal pituitary and follicular activation: A revisited hypothesis in a sheep model. *Reprod. Camb. Engl.* **2016**, *151*, 215–225. [CrossRef]

40. Rawlings, N.C.; Evans, A.C.O.; Honaramooz, A.; Bartlewski, P.M. Antral follicle growth and endocrine changes in prepubertal cattle, sheep and goats. *Anim. Reprod. Sci.* **2003**, *78*, 259–270. [CrossRef]

41. Fuller, G.B.; Faiman, C.; Winter, J.S.; Reyes, F.I.; Hobson, W.C. Sex-dependent gonadotropin concentrations in infant chimpanzees and rhesus monkeys. *Proc. Soc. Exp. Biol. Med.* **1982**, *169*, 494–500. [CrossRef] [PubMed]

42. Aubert, M.L.; Begeot, M.; Winiger, B.P.; Morel, G.; Sizonenko, P.C.; Dubois, P.M. Ontogeny of hypothalamic luteinizing hormone-releasing hormone (GnRH) and pituitary GnRH receptors in fetal and neonatal rats. *Endocrinology* **1985**, *116*, 1565–1576. [CrossRef] [PubMed]

43. Bugnon, C.; Bloch, B.; Lenys, D.; Fellmann, D. Ultrastructural study of the LH-RH containing neurons in the human fetus. *Brain Res.* **1977**, *137*, 175–180. [CrossRef]

44. Paulin, C.; Dubois, M.P.; Barry, J.; Dubois, P.M. Immunofluorescence study of LH-RH producing cells in the human fetal hypothalamus. *Cell Tissue Res.* **1977**, *182*, 341–345. [CrossRef] [PubMed]

45. Groom, G.V.; Boyns, A.R. Effect of hypothalamic releasing factors and steroids on release of gonadotrophins by organ cultures of human foetal pituitaries. *J. Endocrinol.* **1973**, *59*, 511–522. [CrossRef]

46. Bakker, J.; De Mees, C.; Douhard, Q.; Balthazart, J.; Gabant, P.; Szpirer, J.; Szpirer, C. Alpha-fetoprotein protects the developing female mouse brain from masculinization and defeminization by estrogens. *Nat. Neurosci.* **2006**, *9*, 220–226. [CrossRef]

47. Kuiri-Hänninen, T.; Kallio, S.; Seuri, R.; Tyrväinen, E.; Liakka, A.; Tapanainen, J.; Sankilampi, U.; Dunkel, L. Postnatal developmental changes in the pituitary-ovarian axis in preterm and term infant girls. *J. Clin. Endocrinol. Metab.* **2011**, *96*, 3432–3439. [CrossRef]

48. Dulka, E.A.; Moenter, S.M. Prepubertal Development of Gonadotropin-Releasing Hormone Neuron Activity Is Altered by Sex, Age, and Prenatal Androgen Exposure. *Endocrinology* **2017**, *158*, 3943–3953. [CrossRef]

49. Prévot, V. Puberty in Mice and Rats. In *Knobil and Neill's Physiology of Reproduction*, 4th ed.; Elsevier: Amsterdam, The Netherlands, 2015; pp. 1395–1439.

50. Garrel, G.; Racine, C.; L'Hôte, D.; Denoyelle, C.; Guigon, C.J.; di Clemente, N.; Cohen-Tannoudji, J. Anti-Müllerian hormone: A new actor of sexual dimorphism in pituitary gonadotrope activity before puberty. *Sci. Rep.* **2016**, *6*, 23790. [CrossRef]

51. Hau, J.; Svendsen, P.; Teisner, B.; Pederson, G.T.; Kristiansen, B. Correlation between fetal weight and maternal serum levels of murine alpha-fetoprotein and quantitation of four molecular forms. *Biol. Reprod.* **1981**, *24*, 683–689. [CrossRef]

52. Belayew, A.; Tilghman, S.M. Genetic analysis of alpha-fetoprotein synthesis in mice. *Mol. Cell. Biol.* **1982**, *2*, 1427–1435. [CrossRef]

53. Ojeda, S.R.; Ramirez, V.D. Short-term steroid treatment on plasma LH and FSH in castrated rats from birth to puberty. *Neuroendocrinology* **1973**, *13*, 100–114. [CrossRef]

54. Meijs-Roelofs, H.M.; Kramer, P. Maturation of the inhibitory feedback action of oestrogen on follicle-stimulating hormone secretion in the immature female rat: A role for alpha-foetoprotein. *J. Endocrinol.* **1979**, *81*, 199–208. [CrossRef]

55. Plant, T.M. A striking sex difference in the gonadotropin response to gonadectomy during infantile development in the rhesus monkey (Macaca mulatta). *Endocrinology* **1986**, *119*, 539–545. [CrossRef]

56. Kuiri-Hänninen, T.; Dunkel, L.; Sankilampi, U. Sexual dimorphism in postnatal gonadotrophin levels in infancy reflects diverse maturation of the ovarian and testicular hormone synthesis. *Clin. Endocrinol.* **2018**, *89*, 85–92. [CrossRef]

57. Sawyer, H.R.; Smith, P.; Heath, D.A.; Juengel, J.L.; Wakefield, S.J.; McNatty, K.P. Formation of ovarian follicles during fetal development in sheep. *Biol. Reprod.* **2002**, *66*, 1134–1150. [CrossRef]

58. Hirshfield, A.N.; DeSanti, A.M. Patterns of ovarian cell proliferation in rats during the embryonic period and the first three weeks postpartum. *Biol. Reprod.* **1995**, *53*, 1208–1221. [CrossRef]

59. Mazaud, S.; Guyot, R.; Guigon, C.J.; Coudouel, N.; Le Magueresse-Battistoni, B.; Magre, S. Basal membrane remodeling during follicle histogenesis in the rat ovary: Contribution of proteinases of the MMP and PA families. *Dev. Biol.* **2005**, *277*, 403–416. [CrossRef]

60. Mork, L.; Maatouk, D.M.; McMahon, J.A.; Guo, J.J.; Zhang, P.; McMahon, A.P.; Capel, B. Temporal differences in granulosa cell specification in the ovary reflect distinct follicle fates in mice. *Biol. Reprod.* **2012**, *86*, 37. [CrossRef]
34. Penny, R.; Olambiwonnu, N.O.; Frasier, S.D. Serum gonadotropin concentrations during the first four years of life. *J. Clin. Endocrinol. Metab.* **1974**, *38*, 320–321. [CrossRef]

35. Schmidt, H.; Schwarz, H.P. Serum concentrations of LH and FSH in the healthy newborn. *Eur. J. Endocrinol.* **2000**, *143*, 213–215. [CrossRef]

36. Bidlingmaier, F.; Strom, T.M.; Dörr, H.G.; Eisenmenger, W.; Knorr, D. Estrone and estradiol concentrations in human ovaries, testes, and adrenals during the first two years of life. *J. Clin. Endocrinol. Metab.* **1987**, *65*, 862–867. [CrossRef]

37. Dullaart, J.; Kent, J.; Ryle, M. Serum gonadotrophin concentrations in infantile female mice. *J. Reprod. Fertil.* **1975**, *43*, 189–192. [CrossRef]

38. Michael, S.D.; Kaplan, S.B.; Macmillan, B.T. Peripheral plasma concentrations of LH, FSH, prolactin and GH from birth to puberty in male and female mice. *J. Reprod. Fertil.* **1980**, *59*, 217–222. [CrossRef]

39. Torres-Rovira, L.; Succu, S.; Pasciu, V.; Manca, M.E.; Gonzalez-Bulnes, A.; Leoni, G.G.; Pennino, M.G.; Spezzigu, A.; Gallus, M.; Dattena, M.; et al. Postnatal pituitary and follicular activation: A revisited hypothesis in a sheep model. *Reprod. Camb. Engl.* **2016**, *151*, 215–225. [CrossRef]

40. Rawlings, N.C.; Evans, A.C.O.; Honaramooz, A.; Bartlewski, P.M. Antral follicle growth and endocrine changes in prepubertal cattle, sheep and goats. *Anim. Reprod. Sci.* **2003**, *78*, 259–270. [CrossRef]

41. Fuller, G.B.; Faiman, C.; Winter, J.S.; Reyes, F.I.; Hobson, W.C. Sex-dependent gonadotropin concentrations in infant chimpanzees and rhesus monkeys. *Proc. Soc. Exp. Biol. Med.* **1982**, *169*, 494–500. [CrossRef] [PubMed]

42. Aubert, M.L.; Begeot, M.; Winiger, B.P.; Morel, G.; Sizonenko, P.C.; Dubois, P.M. Ontogeny of hypothalamic luteinizing hormone-releasing hormone (GnRH) and pituitary GnRH receptors in fetal and neonatal rats. *Endocrinology* **1985**, *116*, 1565–1576. [CrossRef] [PubMed]

43. Bugnon, C.; Bloch, B.; Lenys, D.; Fellmann, D. Ultrastructural study of the LH-RH containing neurons in the human fetus. *Brain Res.* **1977**, *137*, 175–180. [CrossRef]

44. Paulin, C.; Dubois, M.P.; Barry, J.; Dubois, P.M. Immunofluorescence study of LH-RH producing cells in the human fetal hypothalamus. *Cell Tissue Res.* **1977**, *182*, 341–345. [CrossRef] [PubMed]

45. Groom, G.V.; Boyns, A.R. Effect of hypothalamic releasing factors and steroids on release of gonadotrophins by organ cultures of human foetal pituitaries. *J. Endocrinol.* **1973**, *59*, 511–522. [CrossRef]

46. Bakker, J.; De Mees, C.; Douhard, Q.; Balthazart, J.; Gabant, P.; Szpirer, J.; Szpirer, C. Alpha-fetoprotein protects the developing female mouse brain from masculinization and defeminization by estrogens. *Nat. Neurosci.* **2006**, *9*, 220–226. [CrossRef]

47. Kuiri-Hänninen, T.; Kallio, S.; Seuri, R.; Tyrväinen, E.; Liakka, A.; Tapanainen, J.; Sankilampi, U.; Dunkel, L. Postnatal developmental changes in the pituitary-ovarian axis in preterm and term infant girls. *J. Clin. Endocrinol. Metab.* **2011**, *96*, 3432–3439. [CrossRef]

48. Dulka, E.A.; Moenter, S.M. Prepubertal Development of Gonadotropin-Releasing Hormone Neuron Activity Is Altered by Sex, Age, and Prenatal Androgen Exposure. *Endocrinology* **2017**, *158*, 3943–3953. [CrossRef]

49. Prévot, V. Puberty in Mice and Rats. In *Knobil and Neill's Physiology of Reproduction*, 4th ed.; Elsevier: Amsterdam, The Netherlands, 2015; pp. 1395–1439.

50. Garrel, G.; Racine, C.; L'Hôte, D.; Denoyelle, C.; Guigon, C.J.; di Clemente, N.; Cohen-Tannoudji, J. Anti-Müllerian hormone: A new actor of sexual dimorphism in pituitary gonadotrope activity before puberty. *Sci. Rep.* **2016**, *6*, 23790. [CrossRef]

51. Hau, J.; Svendsen, P.; Teisner, B.; Pederson, G.T.; Kristiansen, B. Correlation between fetal weight and maternal serum levels of murine alpha-fetoprotein and quantitation of four molecular forms. *Biol. Reprod.* **1981**, *24*, 683–689. [CrossRef]

52. Belayew, A.; Tilghman, S.M. Genetic analysis of alpha-fetoprotein synthesis in mice. *Mol. Cell. Biol.* **1982**, *2*, 1427–1435. [CrossRef]

53. Ojeda, S.R.; Ramirez, V.D. Short-term steroid treatment on plasma LH and FSH in castrated rats from birth to puberty. *Neuroendocrinology* **1973**, *13*, 100–114. [CrossRef]

54. Meijs-Roelofs, H.M.; Kramer, P. Maturation of the inhibitory feedback action of oestrogen on follicle-stimulating hormone secretion in the immature female rat: A role for alpha-foetoprotein. *J. Endocrinol.* **1979**, *81*, 199–208. [CrossRef]

55. Plant, T.M. A striking sex difference in the gonadotropin response to gonadectomy during infantile development in the rhesus monkey (Macaca mulatta). *Endocrinology* **1986**, *119*, 539–545. [CrossRef]

56. Kuiri-Hänninen, T.; Dunkel, L.; Sankilampi, U. Sexual dimorphism in postnatal gonadotrophin levels in infancy reflects diverse maturation of the ovarian and testicular hormone synthesis. *Clin. Endocrinol.* **2018**, *89*, 85–92. [CrossRef]

57. Sawyer, H.R.; Smith, P.; Heath, D.A.; Juengel, J.L.; Wakefield, S.J.; McNatty, K.P. Formation of ovarian follicles during fetal development in sheep. *Biol. Reprod.* **2002**, *66*, 1134–1150. [CrossRef]

58. Hirshfield, A.N.; DeSanti, A.M. Patterns of ovarian cell proliferation in rats during the embryonic period and the first three weeks postpartum. *Biol. Reprod.* **1995**, *53*, 1208–1221. [CrossRef]

59. Mazaud, S.; Guyot, R.; Guigon, C.J.; Coudouel, N.; Le Magueresse-Battistoni, B.; Magre, S. Basal membrane remodeling during follicle histogenesis in the rat ovary: Contribution of proteinases of the MMP and PA families. *Dev. Biol.* **2005**, *277*, 403–416. [CrossRef]

60. Mork, L.; Maatouk, D.M.; McMahon, J.A.; Guo, J.J.; Zhang, P.; McMahon, A.P.; Capel, B. Temporal differences in granulosa cell specification in the ovary reflect distinct follicle fates in mice. *Biol. Reprod.* **2012**, *86*, 37. [CrossRef]
61. Harikae, K.; Miura, K.; Shinomura, M.; Matoba, S.; Hiramatsu, R.; Tsunekawa, N.; Kanai-Azuma, M.; Kurohmaru, M.; Morohashi, K.-I.; Kanai, Y. Heterogeneity in sexual bipotentiality and plasticity of granulosa cells in developing mouse ovaries. *J. Cell Sci.* **2013**, *126*, 2834–2844. [CrossRef]

62. Hartshorne, G.M.; Lyrakou, S.; Hamoda, H.; Oloto, E.; Ghafari, F. Oogenesis and cell death in human prenatal ovaries: What are the criteria for oocyte selection? *Mol. Hum. Reprod.* **2009**, *15*, 805–819. [CrossRef] [PubMed]

63. McGee, E.A.; Hsueh, A.J. Initial and cyclic recruitment of ovarian follicles. *Endocr. Rev.* **2000**, *21*, 200–214. [CrossRef] [PubMed]

64. Guigon, C.J.; Mazaud, S.; Forest, M.G.; Brailly-Tabard, S.; Coudouel, N.; Magre, S. Unaltered development of the initial follicular waves and normal pubertal onset in female rats after neonatal deletion of the follicular reserve. *Endocrinology* **2003**, *144*, 3651–3662. [CrossRef] [PubMed]

65. Zheng, W.; Zhang, H.; Gorre, N.; Risal, S.; Shen, Y.; Liu, K. Two classes of ovarian primordial follicles exhibit distinct developmental dynamics and physiological functions. *Hum. Mol. Genet.* **2014**, *23*, 920–928. [CrossRef] [PubMed]

66. Mazaud, S.; Guigon, C.J.; Lozach, A.; Coudouel, N.; Forest, M.G.; Coffigny, H.; Magre, S. Establishment of the reproductive function and transient fertility of female rats lacking primordial follicle stock after fetal gamma-irradiation. *Endocrinology* **2002**, *143*, 4775–4787. [CrossRef]

67. White, S.S.; Ojeda, S.R. Changes in ovarian luteinizing hormone and follicle-stimulating hormone receptor content and in gonadotropin-induced ornithine decarboxylase activity during prepubertal and pubertal development of the female rat. *Endocrinology* **1981**, *109*, 152–161. [CrossRef]

68. Camp, T.A.; Rahal, J.O.; Mayo, K.E. Cellular localization and hormonal regulation of follicle-stimulating hormone and luteinizing hormone receptor messenger RNAs in the rat ovary. *Mol. Endocrinol.* **1991**, *5*, 1405–1417. [CrossRef]

69. Fortune, J.E.; Eppig, J.J. Effects of gonadotropins on steroid secretion by infantile and juvenile mouse ovaries in vitro. *Endocrinology* **1979**, *105*, 760–768. [CrossRef]

70. Balla, A.; Danilovich, N.; Yang, Y.; Sairam, M.R. Dynamics of ovarian development in the FORKO immature mouse: Structural and functional implications for ovarian reserve. *Biol. Reprod.* **2003**, *69*, 1281–1293. [CrossRef]

71. Halpin, D.M.; Jones, A.; Fink, G.; Charlton, H.M. Postnatal ovarian follicle development in hypogonadal (hpg) and normal mice and associated changes in the hypothalamic-pituitary ovarian axis. *J. Reprod. Fertil.* **1986**, *77*, 287–296. [CrossRef]

72. Richards, J.S.; Fitzpatrick, S.L.; Clemens, J.W.; Morris, J.K.; Alliston, T.; Sirois, J. Ovarian cell differentiation: A cascade of multiple hormones, cellular signals, and regulated genes. *Recent Prog. Horm. Res.* **1995**, *50*, 223–254. [CrossRef]

73. Hardy, K.; Fenwick, M.; Mora, J.; Laird, M.; Thomson, K.; Franks, S. Onset and Heterogeneity of Responsiveness to FSH in Mouse Preantral Follicles in Culture. *Endocrinology* **2017**, *158*, 134–147. [CrossRef]

74. di Clemente, N.; Racine, C.; Pierre, A.; Taieb, J. Anti-Müllerian Hormone in Female Reproduction. *Endocr. Rev.* **2021**, *42*, 753–782. [CrossRef]

75. Baarends, W.M.; Uilenbroek, J.T.; Kramer, P.; Hoogerbrugge, J.W.; van Leeuwen, E.C.; Themmen, A.P.; Grootegoed, J.A. Anti-müllerian hormone and anti-müllerian hormone type II receptor messenger ribonucleic acid expression in rat ovaries during postnatal development, the estrous cycle, and gonadotropin-induced follicle growth. *Endocrinology* **1995**, *136*, 4951–4962. [CrossRef]

76. Devillers, M.M.; Petit, F.; Cluzet, V.; François, C.M.; Giton, F.; Garrel, G.; Cohen-Tannoudji, J.; Guigon, C.J. FSH inhibits AMH to support ovarian estradiol synthesis in infantile mice. *J. Endocrinol.* **2019**, *240*, 215–228. [CrossRef]

77. Durlinger, A.L.; Gruijters, M.J.; Kramer, P.; Karels, B.; Kumar, T.R.; Matzuk, M.M.; Rose, U.M.; de Jong, F.H.; Uilenbroek, J.T.; Grootegoed, J.A.; et al. Anti-Müllerian hormone attenuates the effects of FSH on follicle development in the mouse ovary. *Endocrinology* **2001**, *142*, 4891–4899. [CrossRef]

78. Roy, S.; Gandra, D.; Seger, C.; Biswas, A.; Kushnir, V.A.; Gleicher, N.; Kumar, T.R.; Sen, A. Oocyte-Derived Factors (GDF9 and BMP15) and FSH Regulate AMH Expression Via Modulation of H3K27AC in Granulosa Cells. *Endocrinology* **2018**, *159*, 3433–3445. [CrossRef]

79. Cimino, I.; Casoni, F.; Liu, X.; Messina, A.; Parkash, J.; Jamin, S.P.; Catteau-Jonard, S.; Collier, F.; Baroncini, M.; Dewailly, D.; et al. Novel role for anti-Müllerian hormone in the regulation of GnRH neuron excitability and hormone secretion. *Nat. Commun.* **2016**, *7*, 10055. [CrossRef]

80. Lucaccioni, L.; Trevisani, V.; Boncompagni, A.; Marrozzini, L.; Berardi, A.; Iughetti, L. Minipuberty: Looking Back to Understand Moving Forward. *Front. Pediatr.* **2020**, *8*, 612235. [CrossRef]

81. Berger, K.; Eskenazi, B.; Kogut, K.; Parra, K.; Lustig, R.H.; Greenspan, L.C.; Holland, N.; Calafat, A.M.; Ye, X.; Harley, K.G. Association of Prenatal Urinary Concentrations of Phthalates and Bisphenol A and Pubertal Timing in Boys and Girls. *Environ. Health Perspect.* **2018**, *126*, 97004. [CrossRef]

82. Chen, Y.; Wang, Y.; Ding, G.; Tian, Y.; Zhou, Z.; Wang, X.; Shen, L.; Huang, H. Association between bisphenol a exposure and idiopathic central precocious puberty (ICPP) among school-aged girls in Shanghai, China. *Environ. Int.* **2018**, *115*, 410–416. [CrossRef] [PubMed]

83. Busbee, P.B.; Rouse, M.; Nagarkatti, M.; Nagarkatti, P.S. Use of natural AhR ligands as potential therapeutic modalities against inflammatory disorders. *Nutr. Rev.* **2013**, *71*, 353–369. [CrossRef] [PubMed]

84. Baba, T.; Mimura, J.; Nakamura, N.; Harada, N.; Yamamoto, M.; Morohashi, K.-I.; Fujii-Kuriyama, Y. Intrinsic function of the aryl hydrocarbon (dioxin) receptor as a key factor in female reproduction. *Mol. Cell. Biol.* **2005**, *25*, 10040–10051. [CrossRef] [PubMed]
61. Harikae, K.; Miura, K.; Shinomura, M.; Matoba, S.; Hiramatsu, R.; Tsunekawa, N.; Kanai-Azuma, M.; Kurohmaru, M.; Morohashi, K.-I.; Kanai, Y. Heterogeneity in sexual bipotentiality and plasticity of granulosa cells in developing mouse ovaries. *J. Cell Sci.* **2013**, *126*, 2834–2844. [CrossRef]

62. Hartshorne, G.M.; Lyrakou, S.; Hamoda, H.; Oloto, E.; Ghafari, F. Oogenesis and cell death in human prenatal ovaries: What are the criteria for oocyte selection? *Mol. Hum. Reprod.* **2009**, *15*, 805–819. [CrossRef] [PubMed]

63. McGee, E.A.; Hsueh, A.J. Initial and cyclic recruitment of ovarian follicles. *Endocr. Rev.* **2000**, *21*, 200–214. [CrossRef] [PubMed]

64. Guigon, C.J.; Mazaud, S.; Forest, M.G.; Brailly-Tabard, S.; Coudouel, N.; Magre, S. Unaltered development of the initial follicular waves and normal pubertal onset in female rats after neonatal deletion of the follicular reserve. *Endocrinology* **2003**, *144*, 3651–3662. [CrossRef] [PubMed]

65. Zheng, W.; Zhang, H.; Gorre, N.; Risal, S.; Shen, Y.; Liu, K. Two classes of ovarian primordial follicles exhibit distinct developmental dynamics and physiological functions. *Hum. Mol. Genet.* **2014**, *23*, 920–928. [CrossRef] [PubMed]

66. Mazaud, S.; Guigon, C.J.; Lozach, A.; Coudouel, N.; Forest, M.G.; Coffigny, H.; Magre, S. Establishment of the reproductive function and transient fertility of female rats lacking primordial follicle stock after fetal gamma-irradiation. *Endocrinology* **2002**, *143*, 4775–4787. [CrossRef]

67. White, S.S.; Ojeda, S.R. Changes in ovarian luteinizing hormone and follicle-stimulating hormone receptor content and in gonadotropin-induced ornithine decarboxylase activity during prepubertal and pubertal development of the female rat. *Endocrinology* **1981**, *109*, 152–161. [CrossRef]

68. Camp, T.A.; Rahal, J.O.; Mayo, K.E. Cellular localization and hormonal regulation of follicle-stimulating hormone and luteinizing hormone receptor messenger RNAs in the rat ovary. *Mol. Endocrinol.* **1991**, *5*, 1405–1417. [CrossRef]

69. Fortune, J.E.; Eppig, J.J. Effects of gonadotropins on steroid secretion by infantile and juvenile mouse ovaries in vitro. *Endocrinology* **1979**, *105*, 760–768. [CrossRef]

70. Balla, A.; Danilovich, N.; Yang, Y.; Sairam, M.R. Dynamics of ovarian development in the FORKO immature mouse: Structural and functional implications for ovarian reserve. *Biol. Reprod.* **2003**, *69*, 1281–1293. [CrossRef]

71. Halpin, D.M.; Jones, A.; Fink, G.; Charlton, H.M. Postnatal ovarian follicle development in hypogonadal (hpg) and normal mice and associated changes in the hypothalamic-pituitary ovarian axis. *J. Reprod. Fertil.* **1986**, *77*, 287–296. [CrossRef]

72. Richards, J.S.; Fitzpatrick, S.L.; Clemens, J.W.; Morris, J.K.; Alliston, T.; Sirois, J. Ovarian cell differentiation: A cascade of multiple hormones, cellular signals, and regulated genes. *Recent Prog. Horm. Res.* **1995**, *50*, 223–254. [CrossRef]

73. Hardy, K.; Fenwick, M.; Mora, J.; Laird, M.; Thomson, K.; Franks, S. Onset and Heterogeneity of Responsiveness to FSH in Mouse Preantral Follicles in Culture. *Endocrinology* **2017**, *158*, 134–147. [CrossRef]

74. di Clemente, N.; Racine, C.; Pierre, A.; Taieb, J. Anti-Müllerian Hormone in Female Reproduction. *Endocr. Rev.* **2021**, *42*, 753–782. [CrossRef]

75. Baarends, W.M.; Uilenbroek, J.T.; Kramer, P.; Hoogerbrugge, J.W.; van Leeuwen, E.C.; Themmen, A.P.; Grootegoed, J.A. Anti-müllerian hormone and anti-müllerian hormone type II receptor messenger ribonucleic acid expression in rat ovaries during postnatal development, the estrous cycle, and gonadotropin-induced follicle growth. *Endocrinology* **1995**, *136*, 4951–4962. [CrossRef]

76. Devillers, M.M.; Petit, F.; Cluzet, V.; François, C.M.; Giton, F.; Garrel, G.; Cohen-Tannoudji, J.; Guigon, C.J. FSH inhibits AMH to support ovarian estradiol synthesis in infantile mice. *J. Endocrinol.* **2019**, *240*, 215–228. [CrossRef]

77. Durlinger, A.L.; Gruijters, M.J.; Kramer, P.; Karels, B.; Kumar, T.R.; Matzuk, M.M.; Rose, U.M.; de Jong, F.H.; Uilenbroek, J.T.; Grootegoed, J.A.; et al. Anti-Müllerian hormone attenuates the effects of FSH on follicle development in the mouse ovary. *Endocrinology* **2001**, *142*, 4891–4899. [CrossRef]

78. Roy, S.; Gandra, D.; Seger, C.; Biswas, A.; Kushnir, V.A.; Gleicher, N.; Kumar, T.R.; Sen, A. Oocyte-Derived Factors (GDF9 and BMP15) and FSH Regulate AMH Expression Via Modulation of H3K27AC in Granulosa Cells. *Endocrinology* **2018**, *159*, 3433–3445. [CrossRef]

79. Cimino, I.; Casoni, F.; Liu, X.; Messina, A.; Parkash, J.; Jamin, S.P.; Catteau-Jonard, S.; Collier, F.; Baroncini, M.; Dewailly, D.; et al. Novel role for anti-Müllerian hormone in the regulation of GnRH neuron excitability and hormone secretion. *Nat. Commun.* **2016**, *7*, 10055. [CrossRef]

80. Lucaccioni, L.; Trevisani, V.; Boncompagni, A.; Marrozzini, L.; Berardi, A.; Iughetti, L. Minipuberty: Looking Back to Understand Moving Forward. *Front. Pediatr.* **2020**, *8*, 612235. [CrossRef]

81. Berger, K.; Eskenazi, B.; Kogut, K.; Parra, K.; Lustig, R.H.; Greenspan, L.C.; Holland, N.; Calafat, A.M.; Ye, X.; Harley, K.G. Association of Prenatal Urinary Concentrations of Phthalates and Bisphenol A and Pubertal Timing in Boys and Girls. *Environ. Health Perspect.* **2018**, *126*, 97004. [CrossRef]

82. Chen, Y.; Wang, Y.; Ding, G.; Tian, Y.; Zhou, Z.; Wang, X.; Shen, L.; Huang, H. Association between bisphenol a exposure and idiopathic central precocious puberty (ICPP) among school-aged girls in Shanghai, China. *Environ. Int.* **2018**, *115*, 410–416. [CrossRef] [PubMed]

83. Busbee, P.B.; Rouse, M.; Nagarkatti, M.; Nagarkatti, P.S. Use of natural AhR ligands as potential therapeutic modalities against inflammatory disorders. *Nutr. Rev.* **2013**, *71*, 353–369. [CrossRef] [PubMed]

84. Baba, T.; Mimura, J.; Nakamura, N.; Harada, N.; Yamamoto, M.; Morohashi, K.-I.; Fujii-Kuriyama, Y. Intrinsic function of the aryl hydrocarbon (dioxin) receptor as a key factor in female reproduction. *Mol. Cell. Biol.* **2005**, *25*, 10040–10051. [CrossRef] [PubMed]
85. Hernandez-Ochoa, I.; Barnett-Ringgold, K.R.; Dehlinger, S.L.; Gupta, R.K.; Leslie, T.C.; Roby, K.F.; Flaws, J.A. The ability of the aryl hydrocarbon receptor to regulate ovarian follicle growth and estradiol biosynthesis in mice depends on stage of sexual maturity. *Biol. Reprod.* **2010**, *83*, 698–706. [CrossRef] [PubMed]

86. Larigot, L.; Juricek, L.; Dairou, J.; Coumoul, X. AhR signaling pathways and regulatory functions. *Biochim. Open* **2018**, *7*, 1–9. [CrossRef]

87. Patel, S.; Zhou, C.; Rattan, S.; Flaws, J.A. Effects of Endocrine-Disrupting Chemicals on the Ovary. *Biol. Reprod.* **2015**, *93*, 20. [CrossRef]

88. Magre, S.; Rebourcet, D.; Ishaq, M.; Wargnier, R.; Debard, C.; Meugnier, E.; Vidal, H.; Cohen-Tannoudji, J.; Le Magueresse-Battistoni, B. Gender differences in transcriptional signature of developing rat testes and ovaries following embryonic exposure to 2,3,7,8-TCDD. *PLoS ONE* **2012**, *7*, e40306. [CrossRef]

89. Devillers, M.M.; Petit, F.; Giton, F.; François, C.M.; Juricek, L.; Coumoul, X.; Magre, S.; Cohen-Tannoudji, J.; Guigon, C.J. Age-dependent vulnerability of the ovary to AhR-mediated TCDD action before puberty: Evidence from mouse models. *Chemosphere* **2020**, *258*, 127361. [CrossRef]

90. Franceschini, I.; Desroziers, E. Development and Aging of the Kisspeptin-GPR54 System in the Mammalian Brain: What are the Impacts on Female Reproductive Function? *Front. Endocrinol.* **2013**, *4*, 22. [CrossRef]

91. Messager, S.; Chatzidaki, E.E.; Ma, D.; Hendrick, A.G.; Zahn, D.; Dixon, J.; Thresher, R.R.; Malinge, I.; Lomet, D.; Carlton, M.B.L.; et al. Kisspeptin directly stimulates gonadotropin-releasing hormone release via G protein-coupled receptor 54. *Proc. Natl. Acad. Sci. USA* **2005**, *102*, 1761–1766. [CrossRef]

92. Clarkson, J.; Herbison, A.E. Postnatal development of kisspeptin neurons in mouse hypothalamus; sexual dimorphism and projections to gonadotropin-releasing hormone neurons. *Endocrinology* **2006**, *147*, 5817–5825. [CrossRef]

93. Mhaouty-Kodja, S.; Naulé, L.; Capela, D. Sexual Behavior: From Hormonal Regulation to Endocrine Disruption. *Neuroendocrinology* **2018**, *107*, 400–416. [CrossRef]

94. Bakker, J.; Honda, S.-I.; Harada, N.; Balthazart, J. The aromatase knock-out mouse provides new evidence that estradiol is required during development in the female for the expression of sociosexual behaviors in adulthood. *J. Neurosci. Off. J. Soc. Neurosci.* **2002**, *22*, 9104–9112. [CrossRef]

95. Bakker, J.; Pierman, S.; González-Martínez, D. Effects of aromatase mutation (ArKO) on the sexual differentiation of kisspeptin neuronal numbers and their activation by same versus opposite sex urinary pheromones. *Horm. Behav.* **2010**, *57*, 390–395. [CrossRef]

96. Brock, O.; Baum, M.J.; Bakker, J. The development of female sexual behavior requires prepubertal estradiol. *J. Neurosci. Off. J. Soc. Neurosci.* **2011**, *31*, 5574–5578. [CrossRef]

97. Brock, O.; Bakker, J. The two kisspeptin neuronal populations are differentially organized and activated by estradiol in mice. *Endocrinology* **2013**, *154*, 2739–2749. [CrossRef]

98. Clarkson, J. Effects of estradiol on kisspeptin neurons during puberty. *Front. Neuroendocrinol.* **2013**, *34*, 120–131. [CrossRef]

99. Cao, J.; Patisaul, H.B. Sexually dimorphic expression of hypothalamic estrogen receptors α and β and Kiss1 in neonatal male and female rats. *J. Comp. Neurol.* **2011**, *519*, 2954–2977. [CrossRef]

100. Brock, O.; De Mees, C.; Bakker, J. Hypothalamic expression of oestrogen receptor α and androgen receptor is sex-, age- and region-dependent in mice. *J. Neuroendocrinol.* **2015**, *27*, 264–276. [CrossRef]

101. Ikeda, Y.; Kato-Inui, T.; Tagami, A.; Maekawa, M. Expression of progesterone receptor, estrogen receptors α and β, and kisspeptin in the hypothalamus during perinatal development of gonad-lacking steroidogenic factor-1 knockout mice. *Brain Res.* **2019**, *1712*, 167–179. [CrossRef]

102. Naulé, L.; Robert, V.; Parmentier, C.; Martini, M.; Keller, M.; Cohen-Solal, M.; Hardin-Pouzet, H.; Grange-Messent, V.; Franceschini, I.; Mhaouty-Kodja, S. Delayed pubertal onset and prepubertal Kiss1 expression in female mice lacking central oestrogen receptor beta. *Hum. Mol. Genet.* **2015**, *24*, 7326–7338. [CrossRef] [PubMed]

103. Mayer, C.; Acosta-Martinez, M.; Dubois, S.L.; Wolfe, A.; Radovick, S.; Boehm, U.; Levine, J.E. Timing and completion of puberty in female mice depend on estrogen receptor alpha-signaling in kisspeptin neurons. *Proc. Natl. Acad. Sci. USA* **2010**, *107*, 22693–22698. [CrossRef] [PubMed]

104. Trouillet, A.-C.; Ducroq, S.; Naulé, L.; Capela, D.; Parmentier, C.; Radovick, S.; Hardin-Pouzet, H.; Mhaouty-Kodja, S. Deletion of neural estrogen receptor alpha induces sex differential effects on reproductive behavior in mice. *Commun. Biol.* **2022**, *5*, 383. [CrossRef] [PubMed]

105. Kratochwil, K. In vitro analysis of the hormonal basis for the sexual dimorphism in the embryonic development of the mouse mammary gland. *J. Embryol. Exp. Morphol.* **1971**, *25*, 141–153. [CrossRef] [PubMed]

106. Imagawa, W.; Bandyopadhyay, G.K.; Nandi, S. Regulation of mammary epithelial cell growth in mice and rats. *Endocr. Rev.* **1990**, *11*, 494–523. [CrossRef]

107. Haslam, S.Z. The ontogeny of mouse mammary gland responsiveness to ovarian steroid hormones. *Endocrinology* **1989**, *125*, 2766–2772. [CrossRef]

108. Haslam, S.Z.; Nummy, K.A. The ontogeny and cellular distribution of estrogen receptors in normal mouse mammary gland. *J. Steroid Biochem. Mol. Biol.* **1992**, *42*, 589–595. [CrossRef]

109. Feng, Y.; Manka, D.; Wagner, K.-U.; Khan, S.A. Estrogen receptor-alpha expression in the mammary epithelium is required for ductal and alveolar morphogenesis in mice. *Proc. Natl. Acad. Sci. USA* **2007**, *104*, 14718–14723. [CrossRef]
85. Hernandez-Ochoa, I.; Barnett-Ringgold, K.R.; Dehlinger, S.L.; Gupta, R.K.; Leslie, T.C.; Roby, K.F.; Flaws, J.A. The ability of the aryl hydrocarbon receptor to regulate ovarian follicle growth and estradiol biosynthesis in mice depends on stage of sexual maturity. *Biol. Reprod.* **2010**, *83*, 698–706. [CrossRef] [PubMed]

86. Larigot, L.; Juricek, L.; Dairou, J.; Coumoul, X. AhR signaling pathways and regulatory functions. *Biochim. Open* **2018**, *7*, 1–9. [CrossRef]

87. Patel, S.; Zhou, C.; Rattan, S.; Flaws, J.A. Effects of Endocrine-Disrupting Chemicals on the Ovary. *Biol. Reprod.* **2015**, *93*, 20. [CrossRef]

88. Magre, S.; Rebourcet, D.; Ishaq, M.; Wargnier, R.; Debard, C.; Meugnier, E.; Vidal, H.; Cohen-Tannoudji, J.; Le Magueresse-Battistoni, B. Gender differences in transcriptional signature of developing rat testes and ovaries following embryonic exposure to 2,3,7,8-TCDD. *PLoS ONE* **2012**, *7*, e40306. [CrossRef]

89. Devillers, M.M.; Petit, F.; Giton, F.; François, C.M.; Juricek, L.; Coumoul, X.; Magre, S.; Cohen-Tannoudji, J.; Guigon, C.J. Age-dependent vulnerability of the ovary to AhR-mediated TCDD action before puberty: Evidence from mouse models. *Chemosphere* **2020**, *258*, 127361. [CrossRef]

90. Franceschini, I.; Desroziers, E. Development and Aging of the Kisspeptin-GPR54 System in the Mammalian Brain: What are the Impacts on Female Reproductive Function? *Front. Endocrinol.* **2013**, *4*, 22. [CrossRef]

91. Messager, S.; Chatzidaki, E.E.; Ma, D.; Hendrick, A.G.; Zahn, D.; Dixon, J.; Thresher, R.R.; Malinge, I.; Lomet, D.; Carlton, M.B.L.; et al. Kisspeptin directly stimulates gonadotropin-releasing hormone release via G protein-coupled receptor 54. *Proc. Natl. Acad. Sci. USA* **2005**, *102*, 1761–1766. [CrossRef]

92. Clarkson, J.; Herbison, A.E. Postnatal development of kisspeptin neurons in mouse hypothalamus; sexual dimorphism and projections to gonadotropin-releasing hormone neurons. *Endocrinology* **2006**, *147*, 5817–5825. [CrossRef]

93. Mhaouty-Kodja, S.; Naulé, L.; Capela, D. Sexual Behavior: From Hormonal Regulation to Endocrine Disruption. *Neuroendocrinology* **2018**, *107*, 400–416. [CrossRef]

94. Bakker, J.; Honda, S.-I.; Harada, N.; Balthazart, J. The aromatase knock-out mouse provides new evidence that estradiol is required during development in the female for the expression of sociosexual behaviors in adulthood. *J. Neurosci. Off. J. Soc. Neurosci.* **2002**, *22*, 9104–9112. [CrossRef]

95. Bakker, J.; Pierman, S.; González-Martínez, D. Effects of aromatase mutation (ArKO) on the sexual differentiation of kisspeptin neuronal numbers and their activation by same versus opposite sex urinary pheromones. *Horm. Behav.* **2010**, *57*, 390–395. [CrossRef]

96. Brock, O.; Baum, M.J.; Bakker, J. The development of female sexual behavior requires prepubertal estradiol. *J. Neurosci. Off. J. Soc. Neurosci.* **2011**, *31*, 5574–5578. [CrossRef]

97. Brock, O.; Bakker, J. The two kisspeptin neuronal populations are differentially organized and activated by estradiol in mice. *Endocrinology* **2013**, *154*, 2739–2749. [CrossRef]

98. Clarkson, J. Effects of estradiol on kisspeptin neurons during puberty. *Front. Neuroendocrinol.* **2013**, *34*, 120–131. [CrossRef]

99. Cao, J.; Patisaul, H.B. Sexually dimorphic expression of hypothalamic estrogen receptors α and β and Kiss1 in neonatal male and female rats. *J. Comp. Neurol.* **2011**, *519*, 2954–2977. [CrossRef]

100. Brock, O.; De Mees, C.; Bakker, J. Hypothalamic expression of oestrogen receptor α and androgen receptor is sex-, age- and region-dependent in mice. *J. Neuroendocrinol.* **2015**, *27*, 264–276. [CrossRef]

101. Ikeda, Y.; Kato-Inui, T.; Tagami, A.; Maekawa, M. Expression of progesterone receptor, estrogen receptors α and β, and kisspeptin in the hypothalamus during perinatal development of gonad-lacking steroidogenic factor-1 knockout mice. *Brain Res.* **2019**, *1712*, 167–179. [CrossRef]

102. Naulé, L.; Robert, V.; Parmentier, C.; Martini, M.; Keller, M.; Cohen-Solal, M.; Hardin-Pouzet, H.; Grange-Messent, V.; Franceschini, I.; Mhaouty-Kodja, S. Delayed pubertal onset and prepubertal Kiss1 expression in female mice lacking central oestrogen receptor beta. *Hum. Mol. Genet.* **2015**, *24*, 7326–7338. [CrossRef] [PubMed]

103. Mayer, C.; Acosta-Martinez, M.; Dubois, S.L.; Wolfe, A.; Radovick, S.; Boehm, U.; Levine, J.E. Timing and completion of puberty in female mice depend on estrogen receptor alpha-signaling in kisspeptin neurons. *Proc. Natl. Acad. Sci. USA* **2010**, *107*, 22693–22698. [CrossRef] [PubMed]

104. Trouillet, A.-C.; Ducroq, S.; Naulé, L.; Capela, D.; Parmentier, C.; Radovick, S.; Hardin-Pouzet, H.; Mhaouty-Kodja, S. Deletion of neural estrogen receptor alpha induces sex differential effects on reproductive behavior in mice. *Commun. Biol.* **2022**, *5*, 383. [CrossRef] [PubMed]

105. Kratochwil, K. In vitro analysis of the hormonal basis for the sexual dimorphism in the embryonic development of the mouse mammary gland. *J. Embryol. Exp. Morphol.* **1971**, *25*, 141–153. [CrossRef] [PubMed]

106. Imagawa, W.; Bandyopadhyay, G.K.; Nandi, S. Regulation of mammary epithelial cell growth in mice and rats. *Endocr. Rev.* **1990**, *11*, 494–523. [CrossRef]

107. Haslam, S.Z. The ontogeny of mouse mammary gland responsiveness to ovarian steroid hormones. *Endocrinology* **1989**, *125*, 2766–2772. [CrossRef]

108. Haslam, S.Z.; Nummy, K.A. The ontogeny and cellular distribution of estrogen receptors in normal mouse mammary gland. *J. Steroid Biochem. Mol. Biol.* **1992**, *42*, 589–595. [CrossRef]

109. Feng, Y.; Manka, D.; Wagner, K.-U.; Khan, S.A. Estrogen receptor-alpha expression in the mammary epithelium is required for ductal and alveolar morphogenesis in mice. *Proc. Natl. Acad. Sci. USA* **2007**, *104*, 14718–14723. [CrossRef]
110. Purup, S.; Sejrsen, K.; Foldager, J.; Akers, R.M. Effect of exogenous bovine growth hormone and ovariectomy on prepubertal mammary growth, serum hormones and acute in-vitro proliferative response of mammary explants from Holstein heifers. *J. Endocrinol.* **1993**, *139*, 19–26. [CrossRef]

111. Dessauge, F.; Finot, L.; Wiart, S.; Aubry, J.M.; Ellis, S.E. Effects of ovariectomy in prepubertal goats. *J. Physiol. Pharmacol. Off. J. Pol. Physiol. Soc.* **2009**, *60* (Suppl. 3), 127–133.

112. Yart, L.; Lollivier, V.; Marnet, P.G.; Dessauge, F. Role of ovarian secretions in mammary gland development and function in ruminants. *Anim. Int. J. Anim. Biosci.* **2014**, *8*, 72–85. [CrossRef]

113. Yart, L.; Finot, L.; Marnet, P.-G.; Dessauge, F. Suppression of ovarian secretions before puberty strongly affects mammogenesis in the goat. *J. Dairy Res.* **2012**, *79*, 157–167. [CrossRef]

114. Capuco, A.V.; Ellis, S.; Wood, D.L.; Akers, R.M.; Garrett, W. Postnatal mammary ductal growth: Three-dimensional imaging of cell proliferation, effects of estrogen treatment, and expression of steroid receptors in prepubertal calves. *Tissue Cell* **2002**, *34*, 143–154. [CrossRef]

115. Keeling, J.W.; Ozer, E.; King, G.; Walker, F. Oestrogen receptor alpha in female fetal, infant, and child mammary tissue. *J. Pathol.* **2000**, *191*, 449–451. [CrossRef]

116. Kuiri-Hänninen, T.; Haanpää, M.; Turpeinen, U.; Hämäläinen, E.; Seuri, R.; Tyrväinen, E.; Sankilampi, U.; Dunkel, L. Postnatal ovarian activation has effects in estrogen target tissues in infant girls. *J. Clin. Endocrinol. Metab.* **2013**, *98*, 4709–4716. [CrossRef]

117. Trotter, A.; Maier, L.; Kohn, T.; Böhm, W.; Pohlandt, F. Growth of the uterus and mammary glands and vaginal cytologic features in extremely premature infants with postnatal replacement of estradiol and progesterone. *Am. J. Obstet. Gynecol.* **2002**, *186*, 184–188. [CrossRef]

118. Ogasawara, Y.; Okamoto, S.; Kitamura, Y.; Matsumoto, K. Proliferative pattern of uterine cells from birth to adulthood in intact, neonatally castrated, and/or adrenalectomized mice, assayed by incorporation of [125I] iododeoxyuridine. *Endocrinology* **1983**, *113*, 582–587. [CrossRef]

119. Branham, W.S.; Sheehan, D.M. Ovarian and adrenal contributions to postnatal growth and differentiation of the rat uterus. *Biol. Reprod.* **1995**, *53*, 863–872. [CrossRef]

120. Stewart, C.A.; Fisher, S.J.; Wang, Y.; Stewart, M.D.; Hewitt, S.C.; Rodriguez, K.F.; Korach, K.S.; Behringer, R.R. Uterine gland formation in mice is a continuous process, requiring the ovary after puberty, but not after parturition. *Biol. Reprod.* **2011**, *85*, 954–964. [CrossRef]

121. Korach, K.S.; Horigome, T.; Tomooka, Y.; Yamashita, S.; Newbold, R.R.; McLachlan, J.A. Immunodetection of estrogen receptor in epithelial and stromal tissues of neonatal mouse uterus. *Proc. Natl. Acad. Sci. USA* **1988**, *85*, 3334–3337. [CrossRef]

122. Cooke, P.S.; Buchanan, D.L.; Young, P.; Setiawan, T.; Brody, J.; Korach, K.S.; Taylor, J.; Lubahn, D.B.; Cunha, G.R. Stromal estrogen receptors mediate mitogenic effects of estradiol on uterine epithelium. *Proc. Natl. Acad. Sci. USA* **1997**, *94*, 6535–6540. [CrossRef] [PubMed]

123. Klotz, D.M.; Hewitt, S.C.; Ciana, P.; Raviscioni, M.; Lindzey, J.K.; Foley, J.; Maggi, A.; DiAugustine, R.P.; Korach, K.S. Requirement of Estrogen Receptor-α in Insulin-like Growth Factor-1 (IGF-1)-induced Uterine Responses and in Vivo Evidence for IGF-1/Estrogen Receptor Cross-talk. *J. Biol. Chem.* **2002**, *277*, 8531–8537. [CrossRef] [PubMed]

124. Lubahn, D.B.; Moyer, J.S.; Golding, T.S.; Couse, J.F.; Korach, K.S.; Smithies, O. Alteration of reproductive function but not prenatal sexual development after insertional disruption of the mouse estrogen receptor gene. *Proc. Natl. Acad. Sci. USA* **1993**, *90*, 11162–11166. [CrossRef] [PubMed]

125. Curtis, S.W.; Clark, J.; Myers, P.; Korach, K.S. Disruption of estrogen signaling does not prevent progesterone action in the estrogen receptor alpha knockout mouse uterus. *Proc. Natl. Acad. Sci. USA* **1999**, *96*, 3646–3651. [CrossRef] [PubMed]

126. Nanjappa, M.K.; Medrano, T.I.; March, A.G.; Cooke, P.S. Neonatal uterine and vaginal cell proliferation and adenogenesis are independent of estrogen receptor 1 (ESR1) in the mouse. *Biol. Reprod.* **2015**, *92*, 78. [CrossRef]

127. Carpenter, K.D.; Gray, C.A.; Bryan, T.M.; Welsh, T.H.; Spencer, T.E. Estrogen and antiestrogen effects on neonatal ovine uterine development. *Biol. Reprod.* **2003**, *69*, 708–717. [CrossRef]

128. Carpenter, K.D.; Hayashi, K.; Spencer, T.E. Ovarian regulation of endometrial gland morphogenesis and activin-follistatin system in the neonatal ovine uterus. *Biol. Reprod.* **2003**, *69*, 851–860. [CrossRef]

129. Hayashi, K.; O'Connell, A.R.; Juengel, J.L.; McNatty, K.P.; Davis, G.H.; Bazer, F.W.; Spencer, T.E. Postnatal uterine development in Inverdale ewe lambs. *Reprod. Camb. Engl.* **2008**, *135*, 357–365. [CrossRef]

130. Brandenberger, A.W.; Tee, M.K.; Lee, J.Y.; Chao, V.; Jaffe, R.B. Tissue distribution of estrogen receptors alpha (ER-alpha) and beta (ER-beta) mRNA in the midgestational human fetus. *J. Clin. Endocrinol. Metab.* **1997**, *82*, 3509–3512. [CrossRef]

131. WHO (World Health Organization). State of the Science of Endocrine Disrupting Chemicals. 2012. Available online: http://www.who.int/ceh/publications/endocrine/en/ (accessed on 1 April 2022).

132. Viguié, C.; Mhaouty-Kodja, S.; Habert, R.; Chevrier, C.; Michel, C.; Pasquier, E. Evidence-based adverse outcome pathway approach for the identification of BPA as an endocrine disruptor in relation to its effect on the estrous cycle. *Mol. Cell. Endocrinol.* **2018**, *475*, 10–28. [CrossRef]
110. Purup, S.; Sejrsen, K.; Foldager, J.; Akers, R.M. Effect of exogenous bovine growth hormone and ovariectomy on prepubertal mammary growth, serum hormones and acute in-vitro proliferative response of mammary explants from Holstein heifers. *J. Endocrinol.* **1993**, *139*, 19–26. [CrossRef]

111. Dessauge, F.; Finot, L.; Wiart, S.; Aubry, J.M.; Ellis, S.E. Effects of ovariectomy in prepubertal goats. *J. Physiol. Pharmacol. Off. J. Pol. Physiol. Soc.* **2009**, *60* (Suppl. 3), 127–133.

112. Yart, L.; Lollivier, V.; Marnet, P.G.; Dessauge, F. Role of ovarian secretions in mammary gland development and function in ruminants. *Anim. Int. J. Anim. Biosci.* **2014**, *8*, 72–85. [CrossRef]

113. Yart, L.; Finot, L.; Marnet, P.-G.; Dessauge, F. Suppression of ovarian secretions before puberty strongly affects mammogenesis in the goat. *J. Dairy Res.* **2012**, *79*, 157–167. [CrossRef]

114. Capuco, A.V.; Ellis, S.; Wood, D.L.; Akers, R.M.; Garrett, W. Postnatal mammary ductal growth: Three-dimensional imaging of cell proliferation, effects of estrogen treatment, and expression of steroid receptors in prepubertal calves. *Tissue Cell* **2002**, *34*, 143–154. [CrossRef]

115. Keeling, J.W.; Ozer, E.; King, G.; Walker, F. Oestrogen receptor alpha in female fetal, infant, and child mammary tissue. *J. Pathol.* **2000**, *191*, 449–451. [CrossRef]

116. Kuiri-Hänninen, T.; Haanpää, M.; Turpeinen, U.; Hämäläinen, E.; Seuri, R.; Tyrväinen, E.; Sankilampi, U.; Dunkel, L. Postnatal ovarian activation has effects in estrogen target tissues in infant girls. *J. Clin. Endocrinol. Metab.* **2013**, *98*, 4709–4716. [CrossRef]

117. Trotter, A.; Maier, L.; Kohn, T.; Böhm, W.; Pohlandt, F. Growth of the uterus and mammary glands and vaginal cytologic features in extremely premature infants with postnatal replacement of estradiol and progesterone. *Am. J. Obstet. Gynecol.* **2002**, *186*, 184–188. [CrossRef]

118. Ogasawara, Y.; Okamoto, S.; Kitamura, Y.; Matsumoto, K. Proliferative pattern of uterine cells from birth to adulthood in intact, neonatally castrated, and/or adrenalectomized mice, assayed by incorporation of [125I] iododeoxyuridine. *Endocrinology* **1983**, *113*, 582–587. [CrossRef]

119. Branham, W.S.; Sheehan, D.M. Ovarian and adrenal contributions to postnatal growth and differentiation of the rat uterus. *Biol. Reprod.* **1995**, *53*, 863–872. [CrossRef]

120. Stewart, C.A.; Fisher, S.J.; Wang, Y.; Stewart, M.D.; Hewitt, S.C.; Rodriguez, K.F.; Korach, K.S.; Behringer, R.R. Uterine gland formation in mice is a continuous process, requiring the ovary after puberty, but not after parturition. *Biol. Reprod.* **2011**, *85*, 954–964. [CrossRef]

121. Korach, K.S.; Horigome, T.; Tomooka, Y.; Yamashita, S.; Newbold, R.R.; McLachlan, J.A. Immunodetection of estrogen receptor in epithelial and stromal tissues of neonatal mouse uterus. *Proc. Natl. Acad. Sci. USA* **1988**, *85*, 3334–3337. [CrossRef]

122. Cooke, P.S.; Buchanan, D.L.; Young, P.; Setiawan, T.; Brody, J.; Korach, K.S.; Taylor, J.; Lubahn, D.B.; Cunha, G.R. Stromal estrogen receptors mediate mitogenic effects of estradiol on uterine epithelium. *Proc. Natl. Acad. Sci. USA* **1997**, *94*, 6535–6540. [CrossRef] [PubMed]

123. Klotz, D.M.; Hewitt, S.C.; Ciana, P.; Raviscioni, M.; Lindzey, J.K.; Foley, J.; Maggi, A.; DiAugustine, R.P.; Korach, K.S. Requirement of Estrogen Receptor-α in Insulin-like Growth Factor-1 (IGF-1)-induced Uterine Responses and in Vivo Evidence for IGF-1/Estrogen Receptor Cross-talk. *J. Biol. Chem.* **2002**, *277*, 8531–8537. [CrossRef] [PubMed]

124. Lubahn, D.B.; Moyer, J.S.; Golding, T.S.; Couse, J.F.; Korach, K.S.; Smithies, O. Alteration of reproductive function but not prenatal sexual development after insertional disruption of the mouse estrogen receptor gene. *Proc. Natl. Acad. Sci. USA* **1993**, *90*, 11162–11166. [CrossRef] [PubMed]

125. Curtis, S.W.; Clark, J.; Myers, P.; Korach, K.S. Disruption of estrogen signaling does not prevent progesterone action in the estrogen receptor alpha knockout mouse uterus. *Proc. Natl. Acad. Sci. USA* **1999**, *96*, 3646–3651. [CrossRef] [PubMed]

126. Nanjappa, M.K.; Medrano, T.I.; March, A.G.; Cooke, P.S. Neonatal uterine and vaginal cell proliferation and adenogenesis are independent of estrogen receptor 1 (ESR1) in the mouse. *Biol. Reprod.* **2015**, *92*, 78. [CrossRef]

127. Carpenter, K.D.; Gray, C.A.; Bryan, T.M.; Welsh, T.H.; Spencer, T.E. Estrogen and antiestrogen effects on neonatal ovine uterine development. *Biol. Reprod.* **2003**, *69*, 708–717. [CrossRef]

128. Carpenter, K.D.; Hayashi, K.; Spencer, T.E. Ovarian regulation of endometrial gland morphogenesis and activin-follistatin system in the neonatal ovine uterus. *Biol. Reprod.* **2003**, *69*, 851–860. [CrossRef]

129. Hayashi, K.; O'Connell, A.R.; Juengel, J.L.; McNatty, K.P.; Davis, G.H.; Bazer, F.W.; Spencer, T.E. Postnatal uterine development in Inverdale ewe lambs. *Reprod. Camb. Engl.* **2008**, *135*, 357–365. [CrossRef]

130. Brandenberger, A.W.; Tee, M.K.; Lee, J.Y.; Chao, V.; Jaffe, R.B. Tissue distribution of estrogen receptors alpha (ER-alpha) and beta (ER-beta) mRNA in the midgestational human fetus. *J. Clin. Endocrinol. Metab.* **1997**, *82*, 3509–3512. [CrossRef]

131. WHO (World Health Organization). State of the Science of Endocrine Disrupting Chemicals. 2012. Available online: http://www.who.int/ceh/publications/endocrine/en/ (accessed on 1 April 2022).

132. Viguié, C.; Mhaouty-Kodja, S.; Habert, R.; Chevrier, C.; Michel, C.; Pasquier, E. Evidence-based adverse outcome pathway approach for the identification of BPA as an endocrine disruptor in relation to its effect on the estrous cycle. *Mol. Cell. Endocrinol.* **2018**, *475*, 10–28. [CrossRef]